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Abstract 
A primary goal of childhood cancer research is to understand the role of non-
genetic, socially patterned, risk factors in incidence and survival. Many unanswered 
questions persist in the literature that, if answered, may help address this aim. Such 
questions include: do pregnancy-related exposures contribute to the rise in childhood 
cancer incidence over time; is socioeconomic status (SES) associated with childhood 
cancer incidence; and what is the underlying role of social versus biological factors in 
explaining racial disparities in childhood cancer survival? This dissertation addressed 
each of these questions by leveraging population-based data from multiple existing data 
sources, and by employing advanced statistical methods, in three separate investigations.   
In manuscript 1, we conducted a time series ecologic analysis at the county-level 
to test the hypothesis that the temporal rise in childhood cancer incidence is due to 
secular trends in established pregnancy-related risk factors including older maternal age, 
higher birthweight, and smaller family size. We linked population-based cancer registry 
data from the Surveillance, Epidemiology, and End Results (SEER) 9 database (1975-
2013) to natality data from the National Center for Health Statistics (1970-2013). We 
compared the crude average annual percent change (AAPC) in incidence of combined (all 
diagnoses) and individual cancers among children, ages 0-4 years, to AAPCs adjusted for 
pregnancy-related and sociodemographic (race/ethnicity and poverty) factors. AAPCs 
were estimated from Poisson mixed models. In crude models, we found a statistically 
significant temporal rise in incidence of combined childhood cancers (AAPC, 0.71%; 
95% CI, 0.55, 0.86), ALL (0.78%; 0.49, 1.07), AML (1.86%; 1.13, 2.59), CNS tumors 
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(1.31%; 0.94, 1.67), and hepatoblastoma (2.70%; 1.68, 3.72). Contrary to our hypothesis, 
AAPCs remained statistically significantly above 0% in models fully adjusted for county-
level characteristics, though AAPCs were attenuated towards the null for AML (1.62%; 
0.38, 2.87) and hepatoblastoma (2.36%; 0.71, 4.04). Therefore, we did not find 
conclusive evidence that secular trends in established pregnancy-related risk factors 
account for the temporal rise in cancer incidence rates among children, ages 0-4 years. 
In manuscript 2, we tested whether SES, measured at multiple levels of exposure, 
is associated with incidence of childhood cancers after accounting for established 
demographic and pregnancy-related risk factors. We conducted a population-based case-
cohort study using the Minnesota birth registry, 1989-2014, as the source cohort. Cases, 
ages 0-14 years, were identified in the Minnesota Cancer Surveillance System and linked 
to birth records through probabilistic record linkage. Controls were 4:1 frequency 
matched on birth year (2,947 cases, 11,907 controls). We measured individual-level SES 
using maternal education, and we measured neighborhood-level SES using a census tract 
composite index. Associations between SES and childhood cancer incidence were tested 
with logistic mixed models. In crude models, we found that higher maternal education 
was adversely associated with incidence of combined childhood cancers (OR, 1.08; 95% 
CI, 1.04, 1.13), ALL (OR, 1.10; 95% CI, 1.02, 1.19), CNS tumors (OR, 1.12; 95% CI, 
1.04, 1.21), and neuroblastoma (OR, 1.15; 95% CI, 1.02, 1.30). These associations were 
attenuated towards the null, and no longer statistically significant, after adjusting for 
established demographic and pregnancy-related risk factors. Similar patterns were 
observed for neighborhood-level SES. A protective association, robust to covariate 
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control, was detected between higher maternal education and hepatoblastoma risk 
(adjusted OR, 0.70; 95% CI, 0.51, 0.98). Overall, results suggest that, unlike for some 
adult cancers that show strong socioeconomic gradients, associations between SES and 
many childhood cancers appear to be explained by established demographic and 
pregnancy-related risk factors (i.e. non-Hispanic white race/ethnicity, older maternal age, 
and higher birthweight). 
In manuscript 3, we tested whether SES contributes to (i.e. mediates) black-white 
racial disparities in childhood cancer survival. We used population-based survival data 
from the SEER 18 database for black and white children, ages 0-19 years, diagnosed 
2000-2011 (N=27,741). Race was recorded in SEER through medical record abstraction. 
We measured SES using a validated census tract composite index, and we tested 
treatment (first-course cancer-directed surgery and radiation) and distal stage at diagnosis 
as secondary potential mediators. We used the inverse odds weighting (IOW) method to 
test for mediation among combined and individual childhood cancers. Results showed 
that whites have a significant survival advantage over blacks for combined childhood 
cancers, leukemias, lymphomas, CNS tumors, neuroblastoma, and non-
rhabdomyosarcoma soft tissue sarcomas (NRSTS). Significant black-white mortality 
hazard ratios ranged from 1.44 (95% CI, 1.11, 1.87) for NRSTS to 1.91 (95% CI, 1.52, 
2.41) for astrocytomas. SES significantly mediated the race-survival association for 
combined childhood cancers and leukemias, accounting for 20% of the disparity for 
combined childhood cancers (indirect effect HR (iHR), 1.12; 95% CI, 1.08, 1.15), 44% 
for ALL (iHR, 1.18; 95% CI, 1.08, 1.29), and 28% for AML (iHR, 1.16; 95% CI, 1.04, 
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1.29). Treatment and stage significantly mediated race-survival associations for 
astrocytomas (27%; iHR, 1.19; 95% CI, 1.01, 1.40) and neuroblastoma (32%, iHR, 1.16; 
95% CI, 1.04, 1.30). Overall, we found evidence that SES contributes to black-white 
racial disparities in childhood cancer survival, particularly for childhood leukemias. 
However, we could not rule out the possibility that non-social factors also contribute to 
survival differences by race, particularly for astrocytomas and neuroblastoma.  
Taken together, findings from these three investigations suggest that while 
continued study of socioeconomic exposures may generate limited new insight into 
childhood cancer etiology, this line of research may be fruitful for understanding and, 
ultimately, addressing differences in childhood cancer outcomes.  
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Introduction 
Descriptive Epidemiology  
Although rare, cancer is the leading cause of death by disease past infancy among 
children in the United States.1 An estimated 10,270 children, under the age of 15 years, 
will be diagnosed with cancer in 2017 and an estimated 1,190 will die from the disease.2 
Childhood cancer incidence peaks in infancy at about 240 cases per million per year.3,4 
Incidence drops to a low of 128 cases per million per year between ages 5 and 9 years,3,4 
before rising to about 220 cases per million per year between ages 15 and 19 years.3,4 
Childhood cancer is not a single disease entity, but rather a spectrum of different 
malignancies that vary by histology, epidemiology, site of disease origin, and etiology.5 
Classifications of Childhood Cancer 
The types of cancers that develop in children often differ from those in adults. 
Unlike adult cancers, which are generally classified by the primary site of tumor origin, 
childhood cancers are more appropriately classified by morphology.5 Leukemias are the 
most common type of cancer among children, accounting for approximately 30% of 
pediatric malignancies.5 Leukemias arise in the hematopoietic system, most often 
involving malignant transformation of lymphoid progenitor cells or, to a lesser extent, 
myeloid progenitor cells.5 Central nervous system (CNS) tumors, a heterogeneous group 
of neoplasms that originate in the brain, are the second most common type of cancer 
among children, accounting for approximately 17% of malignancies.5 Astrocytomas, 
which arise from astrocytes, account for about half of all malignant CNS tumors.5 
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Lymphomas represent the third most common type of childhood cancer, accounting for 
approximately 15% of malignancies.5 Lymphomas are rare among young children, with 
rising rates in adolescence.5 Lymphomas arise from lymphocytes and are commonly 
classified into two etiologically distinct subgroups: Hodgkin lymphoma, which arises 
from B-lymphocytes with characteristic Reed-Sternberg cells, and non-Hodgkin 
lymphoma, which includes various histological subtypes.5 Malignant bone tumors, such 
as osteosarcoma and Ewing’s sarcoma, are also more common among older children and 
adolescents.5 Conversely, embryonal tumors, which arise from aberrant development of 
stems cells, are more common among younger children.5 Types of embryonal tumors 
include neuroblastoma (arising from neural crest cells), retinoblastoma (arising in the 
retina or, extremely rarely, in the pineal gland), Wilms’ tumor (arising from primitive 
metanephric blastemal), and hepatoblastoma (arising from immature liver precursor 
cells).5 Finally, soft tissue sarcomas (STS), which are primarily of mesenchymal cell 
origin, and germ cell tumors (GCT) are two heterogeneous groups of tumors that occur in 
children.5 Other types of childhood cancers, such as carcinomas,5 are rare and not often 
studied in isolation.  
Etiology of Childhood Cancer 
Due to the rarity of childhood cancers, progress in understanding the etiology of 
these diseases has been slow, though advances have been made over time.3 
Demographic Factors – Incidence varies by demographic factors including age, 
sex, and race/ethnicity.5 For most childhood cancers, incidence is slightly higher among 
males compared to females, though Wilms’ tumor is a notable exception.3,5 Incidence is 
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also higher among non-Hispanic white children for many, but not all, types of cancer.5 
For example, the incidence of acute lymphoblastic leukemia (ALL) is about 10% higher 
in Hispanic children compared to non-Hispanic white children.3  
Genetic Factors – Efforts to sort out the role of genetic versus non-genetic risk 
factors in childhood cancer etiology are ongoing. Inherited syndromes caused by high-
penetrance germline DNA mutations, chromosomal aneuploidy, or epigenetic disorders 
are estimated to account for 5 to 10% of childhood malignancies.3 Examples of 
associated syndromes include trisomy 21 (Down syndrome) and leukemia;6,7 Li-
Fraumeni syndrome and STS, osteosarcoma, and CNS tumors;8 and neurofibromatosis 
types 1 and 2 and CNS tumors.8 The proportion of disease attributed to inherited 
syndromes may be much higher for rare cancers,3 such as adrenocortical carcinomas.9  
Findings from genome-wide association studies (GWAS) suggest that common 
genetic variants may explain a greater proportion of the population-attributable risk for 
childhood compared to adult cancers.3 For example, GWAS conducted among racially 
and ethnically diverse subjects provide evidence of an association between the ARID5B 
rs10821936 polymorphism and increased risk of ALL.3,10 Further, these studies 
demonstrate variability in allele frequency across racial and ethnic groups, with 33% 
presentation in Europeans, 27% in African Americans, and 47% in Hispanics.3,10 Thus, 
this line of research may help explain noted racial and ethnic differences in incidence.  
Infection – Exposure to infections may contribute to risk of some childhood 
cancers. There is evidence that Epstein-Barr virus increases risk of Burkitt’s lymphoma 
and possibly some subtypes of Hodgkin lymphoma.11 Further, studies of parental 
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occupational contact, population mixing, daycare attendance, and medical histories 
provide some indirect evidence of a possible infectious etiology of other childhood 
cancers, particularly ALL,12,13 though no specific viruses have been identified.3,12,13  
There are two main hypotheses for a possible association between delayed 
exposure to infection and ALL risk. Greaves proposed a two-hit hypothesis in which 
ALL arises as a consequence of at least two independent mutations.14,15 The first 
leukemic translocation is initiated in utero.14,15 If a child experiences limited exposure to 
infections in the first year of life, the risk of a subsequent mutation(s) increases due to 
improper immune system development, thus eliciting an abnormal proliferative 
response.14,15 Greaves’ hypothesis is supported by evidence from studies of the clonal 
relationship of concordant leukemia in identical, monozygotic, twins,16 and from 
‘backtracking’ studies that screened for fusion-gene sequences in DNA from archived 
Guthrie cards.17,18 Alternatively, Kinlen proposed that clusters of childhood ALL arise 
from population mixing, which occurs when a relatively unexposed, immunologically 
naïve, population is introduced to a new virus, which then leads to lymphoproliferative 
stress.19,20 Kinlen’s hypothesis is supported by a recent meta-analysis that estimated an 
increased risk of ALL in rural settings of population mixing.21 Other hypotheses include 
Smith’s hygiene hypothesis, which theorizes that improved hygiene decreases a mother’s 
chances of having protective antibodies against an unknown leukemic agent,22 and 
Schmiegelow’s adrenal hypothesis, which theorizes that early exposure to infection 
reduces ALL risk through a direct anti-leukemic cortisol effect and modification of the T-
helper-1/T-helper-2 balance.23  
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Pregnancy-Related Factors – Given the early onset of many childhood cancers, 
pregnancy-related factors are thought to contribute to etiology. Prior studies have linked 
maternal age, birthweight, and birth order with many, if not most, childhood cancers.3 A 
large pooled analysis of population-based record-linkage studies, conducted by Johnson 
et al. (2009), found significant positive linear trends between increasing maternal age and 
risk of combined childhood cancers (all diagnoses), leukemias, lymphomas, CNS tumors, 
neuroblastoma, Wilms’ tumor, bone tumors, and STS.24 Estimated associations ranged 
from 6 to 15% increased risk per 5-year increase in maternal age.24 The underlying cause 
of the association between advanced maternal age and childhood cancer risk is not 
currently known. Proposed mechanisms include differential expression of cell cycle 
control genes, DNA damage to response and repair pathways, age-related decreases in 
oocyte gene expression, and increased de novo epimutations in oocyte genes.24,25 Other 
potential explanations include assisted reproductive technology use26 and age-related 
changes in hormone levels during pregnancy.24  
Risk of ALL, CNS tumors, neuroblastoma, and Wilms’ tumor are shown to rise as 
a linear function of birthweight, though to varying magnitudes.3 Acute myeloid leukemia 
(AML) risk is elevated with low and high birthweight.3 Hepatoblastoma risk is inversely 
associated with birthweight, with strikingly elevated risk among the smallest infants.3,27 
Recent studies using alternative measures of birth size, such as size for gestational age 
and percent of optimal birthweight, demonstrate similar associations.3 As with maternal 
age, the reasons for birthweight associations are not known, but may include prenatal 
growth hormone exposure, an increased number of cells at risk of carcinogenic 
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transformation, or underlying genetic factors associated with birthweight.3 For example, 
the role of the insulin-like growth factor system in childhood cancer risk is a promising 
area of research.28 The strong inverse association between birthweight and 
hepatoblastoma risk may be due to medical exposures in the neonatal intensive care unit, 
such as irradiation and oxidative stress, combined with the immature defense mechanisms 
of premature infants, though no definitive exposures have been identified.27 
A large pooled analysis of population-based record-linkage studies, conducted by 
Von Behren et al. (2011), reported an inverse association between birth order and risk of 
combined childhood cancers, ALL, CNS tumors, neuroblastoma, bilateral retinoblastoma, 
Wilms’ tumor, and rhabdomyosarcoma.29 A positive association between increasing birth 
order and AML risk was also observed.29 Birth order may be a marker of other potential 
risk factors, such as infection.29 Later born children may be exposed to infections at 
earlier ages than first born children through contact with older siblings, though this may 
not hold if the birth interval is large, or if infections are acquired from other sources, such 
as daycare attendance.29 Birth order may also be a marker of differential hormone 
exposures in utero,29 which may influence cancer risk.30,31 Estrogen levels in maternal 
and umbilical cord blood samples are shown to be somewhat higher in the first pregnancy 
compared with second and third pregnancies.32-34 
 Other pregnancy-related exposures have been studied in the childhood cancer 
literature including maternal substance use,35-37 vitamin use,38 and exposure to residential 
and occupational pesticides.39-41 However, no definitive associations have emerged 
among these types of exposures.3     
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Socioeconomic Status – Socioeconomic status (SES) is a multidimensional 
construct that encompasses both economic resources and social standing.42,43 SES is 
consistently linked to a range of health outcomes in children and adults including many 
adulthood cancers.44-46 However, evidence of an association between SES and childhood 
cancer incidence remains limited and inconsistent. Prior studies of SES have been largely 
confined to childhood leukemias, and ALL in particular. This is likely because of the 
relatively high incidence of leukemias in children, as well as the hypothesized infectious 
etiology of ALL, which may be socially patterned.13,47,48 Due to the lack of individual-
level socioeconomic data in cancer registries and medical records,49 studies of SES and 
childhood cancer risk have been mostly ecological in design, especially in earlier years. 
Ecologic studies have used a variety of measures to operationalize SES, including area-
level income, education, occupation, and composite indices.50-54 Findings from these 
studies generally suggest an adverse association between higher SES and childhood 
cancer risk.50-54 Though few studies have tested associations of SES and childhood cancer 
risk at the individual-level, among those that have, null associations between SES and 
childhood cancer risk have mostly been reported.43,55-59 A recent study by Heck et al. 
(2016) did find lower risk of several cancers among Hispanic children of foreign born 
mothers compared to Hispanic children of US born mothers.60 Although nativity is not a 
direct measure of SES, this study provides some individual-level evidence that 
environmental, social, and cultural factors may contribute to childhood cancer risk.60 
Given the potential biases that can arise in ecologic studies,61 as well as the limited 
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evidence of an association at the individual-level, further research is needed to clarify 
associations of SES and childhood cancer risk. 
Despite the lack of conclusive empirical evidence, there is theoretical grounding 
for a potential association between SES and childhood cancer risk. As previously stated, 
SES may drive patterns of exposure to infections, which in turn may influence risk of 
some childhood cancers.11,12 The differential distribution of ALL and Hodgkin lymphoma 
in the pediatric population of high-income versus low-income countries provides some 
indirect support for this hypothesis.52 SES may also influence risk through the social 
patterning of established pregnancy-related exposures, such as maternal age, birthweight, 
and birth order.3 Women of higher SES are more likely to delay childbearing and have 
fewer children than women of lower SES.62 Further, high SES women are at lower risk of 
adverse birth outcomes, including low birthweight and small for gestational age, than low 
SES women.63 Finally, SES may influence risk through environmental exposures, such as 
air pollutants, pesticides, and parental substance use.64-66 However, besides high-dose 
ionizing radiation and prior chemotherapy, no environmental exposures have emerged as 
definitive causes of childhood cancer.3 A better understanding of the relationship between 
SES and childhood cancer risk may provide etiologic insight into the role of such 
exogenous exposures. 
Temporal Trends in Incidence 
The incidence of combined childhood cancers has gradually increased in the 
United States by approximately 0.6% per year since 1975.2 During this period, incidence 
has also increased for several individual childhood cancers including leukemias, CNS 
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tumors, hepatoblastoma, STS, and GCT.67 The underlying cause of increasing incidence 
rates is not currently known. Some researchers speculate that rising rates may be an 
artifact of changes over time in diagnostic technology, disease classification, and registry 
completeness.68-70 For example, the sharp increase in CNS tumor diagnoses in the 1980s 
is thought to be attributed to the introduction of magnetic resonance imaging and 
stereotactic biopsy.68 Diagnostic changes are less likely to explain the observed rise in 
other types of childhood cancer, such as childhood leukemias.68  
Others hypothesize that rising rates reflect a true increase in incidence attributed 
to changes over time in exogenous risk factors, such as environmental exposures (e.g. 
low-level radiation).71-73 However, as previously noted, there is little empirical evidence 
linking such exposures to childhood cancer risk.3 Further, some environmental pollutants 
have decreased in the United States since the introduction of the Clean Air Act in 1970.74 
A more plausible hypothesis is that the rise in childhood cancer incidence is due to an 
increase over time in established pregnancy-related exposures, such as older maternal 
age, heavier birthweight, and decreased parity.3 A population-level shift in recent decades 
towards delayed childbearing and smaller family size is well documented in the United 
States,62 and rising overweight and obesity rates are speculated to have influenced 
birthweight trends.75,76 To date, limited work has been done to empirically test this 
hypothesis. An age-period-cohort study in Piedmont, Italy, conducted by Maule et al. 
(2007), found a positive association between increasing maternal age and ALL incidence 
over time.77 However, this study did not account for potential confounders, such as 
birthweight and parity, nor did it consider other childhood cancers, besides ALL, that also 
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demonstrate associations with maternal age.24 Additional time series research is needed to 
better understand the role of pregnancy-related exposures, as well as other potential risk 
factors, in explaining temporal trends in childhood cancer incidence.  
Childhood Cancer Survival 
Childhood cancer survival has improved markedly over the past 30 years due to 
new and improved treatments and standardization in care of the pediatric population.67 
The 5-year survival rate for combined childhood cancers increased from 58% in the mid-
1970s to 82% between 2003 and 2009.78 However, survival rates vary considerably by 
patient and tumor characteristics, such as age at diagnosis and cancer type.5 Survival also 
varies by race and ethnicity, with the largest disparity documented between non-Hispanic 
black and non-Hispanic white children.67 Based on 2005-2011 estimates, the 5-year 
survival rate for combined childhood cancers was only 78% among non-Hispanic blacks, 
ages 0 to 19 years, compared to 85% among non-Hispanic whites.4 Black-white racial 
disparities in survival are also documented for several individual childhood cancers 
including leukemias,79-81 lymphomas,82-84 CNS tumors,85 and some extracranial solid 
tumors.86-88 The reasons for differences in survival by race are not well understood, with 
both biological and socioeconomic mechanisms proposed in the literature.89  
There is some evidence suggesting that underlying genetic variations associated 
with ancestry may lead to differences in tumor biology for some childhood cancers.90,91 
For example, several studies demonstrate that high white blood cell count and older age 
at presentation contribute to the overrepresentation of black children in the ALL high-risk 
group.92-94 A study by Metzger et al. (2008) reported a greater proportion of high-risk 
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features among black compared to white Hodgkin lymphoma pediatric patients including 
advanced stage at diagnosis, low hemoglobin levels, and high erythrocyte 
sedimentation.95 A study by Baker et al. (2002) reported a greater proportion of high-risk 
features among non-white compared to white rhabdomyosarcoma pediatric patients 
including presentation with invasive T2 tumors, positive regional lymph nodes, larger 
tumor size, and advanced stage at diagnosis.96 Because these studies largely relied on 
comparisons of clinical characteristics, a more sophisticated molecular understanding of 
differences in disease biology across racial and ethnic groups is needed.90 
There is also some evidence that variability in pharmacogenomics may contribute 
to survival differences by race.90 For example, the antimetabolite 6-mercaptopurine, 
which is used to treat ALL, is found to be more active in patients with genetic deficiency 
of thiopurine methyl transferase, an enzyme involved in detoxification.97 Variation in the 
frequency and distribution of mutant alleles by ancestry has been shown.98-102 Variability 
in enzymes, such as CYP3A4, responsible for the metabolism of drugs, such as alkylating 
agents and vinca alkaloids, may also contribute to observed survival differences.93 
 However, race is a socially constructed taxonomy that is not synonymous with 
ancestry.91 Race is highly correlated with SES,103,104 especially in the United States where 
embedded institutionalized racism continues to place racial and ethnic minorities at high 
risk of low SES.105 Empirical evidence of an association between SES and childhood 
cancer survival is emerging. A 2014 systematic review by Gupta et al. positively linked 
higher SES to improved survival from combined childhood cancers,106 a 2014 meta-
analysis by Petridou et al. positively linked SES to survival from childhood leukemias,107 
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and evidence is emerging positively linking SES to survival from types of childhood 
solid tumors.85,87,108 Therefore, it is plausible that SES also contributes to documented 
survival differences by race. Underlying mechanisms linking SES to childhood cancer 
survival may include early diagnosis and entry into care, ready access to quality health 
care including clinical trial enrollment, and sufficient time and energy to maintain 
adherence to therapy.90 More work is needed to disentangle the relative role of social 
versus biological mechanisms in explaining racial and ethnic disparities in childhood 
cancer survival.  
Dissertation Objective 
A primary goal of childhood cancer research is to understand the role of non-
genetic, socially patterned, risk factors in incidence and survival. Many unanswered 
questions persist in the literature that, if answered, may help address this aim. Such 
questions include: do pregnancy-related exposures contribute to the rise in childhood 
cancer incidence over time; is there an association between SES and childhood cancer 
incidence; and what is the underlying role of social versus biological factors in explaining 
racial survival disparities? Efforts to address these questions have been hampered by the 
dearth of robust, population-based, data available to rigorously test childhood cancer 
associations. Progress has also been slowed by the underutilization of advanced statistical 
methods, such as multilevel modeling, in the childhood cancer literature. Innovative 
approaches to data collection and analysis are needed to move the field forward in 
understanding socially patterned risk factors of childhood cancer incidence and survival. 
This dissertation contributes to the childhood cancer literature by rigorously testing each 
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of the previously defined research questions in three separate investigations using 
population-based registry data from multiple existing data sources and advanced 
statistical methods.   
Manuscript 1 – The aim of this study was to investigate whether temporal trends 
in pregnancy-related risk factors contribute to the rise in childhood cancer incidence over 
time. To achieve this aim, we conducted a time series ecologic analysis at the county-
level. We used population-based birth and cancer registry data linked from the National 
Center for Health Statistics and the Surveillance, Epidemiology, and End Results (SEER) 
program. We tested temporal associations using Poisson mixed models. We assessed 
multiple pregnancy-related risk factors including maternal age, birthweight, and birth 
order; we adjusted for temporal trends in county-level sociodemographic factors 
including race, ethnicity, and poverty; and we tested associations for combined and 
individual childhood cancers including types of leukemias and solid tumors. We 
hypothesized that population-level shifts towards older maternal age, higher birthweight, 
and smaller family size contribute to the rise in childhood cancer incidence over time.  
Manuscript 2 – The aim of this study was to determine if SES, measured at 
multiple levels of exposure, is associated with childhood cancer incidence. We conducted 
a population-based case-cohort study through linkage of data from Minnesota birth and 
cancer registries. We tested measures of SES at both the individual-level and 
neighborhood-level to potentially reconcile contradictory findings from prior ecologic 
and individual-level studies. We tested associations using logistic mixed models, and we 
accounted for established demographic and pregnancy-related risk factors that may 
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confound or mediate associations of SES and childhood cancer incidence. We 
hypothesized that higher SES is adversely associated with childhood cancer incidence, 
which is due, at least in part, to the social patterning of established demographic and 
pregnancy-related risk factors.  
Manuscript 3 – The aim of this study was to determine if SES mediates the 
association between race (black versus white) and childhood cancer survival and, if so, to 
what degree. We also tested prognostic factors, including tumor stage and treatment, as 
other potential mediators of the race-survival association. We employed the 
semiparametric inverse odds weighting method to formally test for mediation. We used 
population-based SEER data representative of the US pediatric cancer population, and we 
assessed survival from combined and individual childhood cancers to determine if 
mediation differs across tumor groups. We hypothesized that SES contributes to (i.e. 
mediates) the association between race and survival, and thus, after accounting for the 
mediating pathway of SES, black-white racial disparities in childhood cancer survival 
will be attenuated.  
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Manuscript 1: Do pregnancy-related risk factors contribute to 
rising childhood cancer incidence rates in the United States? 
Introduction 
Since 1975, the overall childhood cancer incidence rate has been gradually 
increasing in the United States at an annual rate of approximately 0.6% per year.2 During 
this period, incidence rates have also increased for several individual types of childhood 
cancer including leukemias, central nervous system (CNS) tumors, and hepatoblastoma.67 
The underlying cause of rising rates is not known, and few studies have conducted time 
series analyses to understand trends. Some researchers speculate that rising rates may 
reflect changes over time in diagnostic technology, disease classification, and registry 
completeness.68-70 For example, it is thought that the sharp increase in CNS tumor 
diagnoses in the 1980s was due to the introduction of magnetic resonance imaging and 
stereotactic biopsy.68  However, there are also plausible explanations for why the 
documented rise may reflect a true increase in disease. We hypothesize that rising 
incidence rates are attributed to increases over time in established pregnancy-related risk 
factors including older maternal age, higher birthweight, and reduced parity.3 A 
population-level shift in recent decades towards delayed childbearing and smaller family 
size is well documented in the United States.62 Further, rising overweight and obesity 
rates are speculated to have influenced birthweight trends.109,110 Mounting evidence links 
these pregnancy-related exposures to many, if not most, childhood cancers.3,24,29,111 
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Therefore, it is reasonable to suppose that some proportion of the rise in childhood cancer 
incidence is due to secular trends in these established risk factors. 
To our knowledge, only one prior study has empirically tested temporal 
associations between pregnancy-related risk factors and cancer incidence in the childhood 
cancer literature. Maule et al. (2007) conducted an individual-level age-period-cohort 
study in Piedmont, Italy to test temporal associations between maternal age and acute 
lymphoblastic leukemia (ALL) incidence.77 Study results suggest that a trend towards 
older maternal age does explain, at least in part, the increase in ALL incidence over 
time.77 However, this study was confined to only 252 cases of ALL diagnosed between 
1980 and 1997. Other types of childhood cancer, which also demonstrate individual-level 
associations with maternal age,24 were not considered. Further, this study did not account 
for potential confounding by other risk factors, such as birthweight and birth order. 
Additional research is needed to more thoroughly describe temporal associations between 
established pregnancy-related risk factors and childhood cancer incidence. We conducted 
a time series ecologic analysis using population-based registry data in the United States 
to test associations between county-level trends in pregnancy-related risk factors and 
childhood cancer incidence over a 39-year period. We assessed multiple risk factors 
including maternal age, birthweight, and birth order; we adjusted for temporal trends in 
county-level sociodemographic characteristics including race, ethnicity, and poverty; and 
we tested associations for combined and individual childhood cancers including types of 
leukemias and solid tumors. We hypothesized that adjustment for county-level temporal 
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trends in pregnancy-related risk factors would attenuate the estimated average annual 
percent change (AAPC) in childhood cancer incidence.   
Methods 
Study Population 
Our study sample consisted of 194 counties from eight cancer registries included 
in the Surveillance, Epidemiology, and End Results (SEER) 9 database (1975-2013): 
Atlanta, Connecticut, Detroit, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget 
Sound, and Utah.78 We linked county-level aggregated cancer data, based on addresses at 
time of diagnosis, to county-level aggregated birth data with the assumption that county 
of residence was stable from birth to diagnosis. To minimize bias from this assumption, 
we restricted county incidence rates to younger children, ages 0 to 4 years, given that 
older children are more residentially mobile.112 Between 1975 and 2013, average county 
population size of children, ages 0 to 4 years, in our sample was 8,769 (SD = 20,139), 
ranging from 22 children in Harding County, NM (2002, 2004) to 201,142 children in 
Wayne County, MI (1975).  
Data Linkage 
Our analysis was made feasible through linkage of data from three sources: (1) 
SEER, (2) the National Center for Health Statistics (NCHS), and (3) the US Census 
Bureau. Data were merged at the county-level using Federal Information Processing 
Standard (FIPS) identifiers. We obtained annual county-level incidence rates, 1975 to 
2013, for children, aged 0 to 4 years, from the SEER database. Denominators were based 
on US Census Bureau annual population estimates. Incidence rates were estimated for 
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combined childhood cancers (all diagnoses) and for individual cancers occurring among 
younger children including ALL, acute myeloid leukemia (AML), combined CNS 
tumors, neuroblastoma, retinoblastoma, Wilms’ tumor, and hepatoblastoma. Cancers 
were classified using the International Classification of Childhood Cancer, third 
edition.113 We were granted access to annual birth files with county identifiers, 1970 to 
2013, from the NCHS. We aggregated pregnancy-related factors from birth records 
including maternal age (years), birthweight (grams), and live birth order (0-8+) and 
estimated county-level means, averaged over the 6-year birth window corresponding to 
year of diagnosis. For example, 1975 cancer incidence rates for children, ages 0 to 4 
years, include cases born between 1970 and 1975; therefore 1975 incidence rates were 
linked to birth data averaged 1970-1975. We linked county-level demographic and 
socioeconomic measures from the US Census including proportion of residents, ages 0-4 
years, classified as white race (%white) and Hispanic ethnicity (%Hispanic); and 
proportion of residents, all ages, below the poverty line (%poverty). Data on race were 
available from annual population estimates, while data on ethnicity (1980-2010) and 
poverty (1970-2010) were only available from decennial censuses. We linearly 
interpolated intercensal years so that, for example, a county with 10% Hispanic children 
in 1990 and 20% in 2000 would be assigned a value of 11% Hispanic in 1991. Because 
ethnicity data were not available from the 1970 census, we used 1980 values to impute 
%Hispanic for years 1975-1979.  
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Statistical Analysis 
Among our sample of 194 counties, we descriptively assessed overall trends in 
cancer incidence and county-level characteristics by graphing annual rates and means 
between 1975 and 2013. We estimated annual trends in county-level characteristics from 
linear mixed models with a random intercept for repeated county-level measures over 
time; a quadratic term for time was included in the model predicting birthweight. We 
tested associations of county-level characteristics predicting childhood cancer incidence 
in Poisson mixed models with a random intercept for repeated county-level measures 
over time. The model implicitly controls for heterogeneity in population size by 
specifying incidence rate denominators (county population of children aged 0-4) in the 
offset term. We tested associations between each county-level characteristic and 
childhood cancer incidence, first in models adjusted only for year of diagnosis, and then 
in models further adjusted for all other county-level characteristics. Rate ratios (RR) and 
95% confidence intervals (CI) were estimated for a 5-year change in county-level average 
maternal age, a 500-gram change in county-level average birthweight, a 1-unit change in 
county-level average birth order, and a 10% change in county-level %white, %Hispanic, 
and %poverty. We tested for interactions between county-level characteristics and year of 
diagnosis, but found none were significant in adjusted models.  
We estimated the crude AAPC from a Poisson mixed model with only year of 
diagnosis predicting cancer incidence [AAPC = (eβyeardx – 1)*100)]. For cancers in which 
incidence significantly changed over time in crude models, we estimated the percent 
change between the crude AAPC and AAPCs adjusted for county-level characteristics 
 20 
 
[%change = ((βyeardxadjusted–βyeardxcrude)/ βyeardxcrude)]. We calculated AAPCs from 
models adjusted for each county-level characteristic one at a time (e.g. a model 
specifying year of diagnosis and maternal age predicting incidence), and from models 
fully adjusted for all county-level characteristics simultaneously. As a secondary analysis, 
we tested models specifying the baseline value and the change from baseline for each 
county-level characteristic, but found no substantial differences from crude estimates 
(results not presented). We tested the null hypothesis (AAPC = 0%) using a two-sided 
test; statistical significance was determined as p <.05. Analyses were performed using 
Stata 14.2 (College Station, TX).114  
Results 
In Table 2-1, we present county-level characteristics averaged over the first 
(1975-1980) and last (2008-2013) six years of the study period. Over the study period, 
average maternal age increased from 24.8 years (standard deviation (SD), 0.7) in 1975-
1980 to 27.0 years (SD, 1.4) in 2008-2013, while average birthweight slightly decreased 
from 3,361 grams (SD, 102) to 3,300 grams (SD, 89). Average %white decreased from 
95.0% (SD, 10.5) in 1975-1980 to 89.4% (SD, 13.3) in 2008-2013, while average 
%Hispanic increased from 9.8% (SD, 19.0) to 19.2% (SD, 21.2). Average live birth order 
and %poverty remained stable over the study period.  
Annual trends in county-level characteristics are depicted in Figure 2-1. Temporal 
trends further demonstrate that, over the study period, average county-level maternal age 
(β, 0.068; 95% CI, 0.067, 0.070) and %Hispanic (β, 0.30; 95% CI, 0.29, 0.30) increased, 
average %white (β, -0.17; 95% CI, -0.17, -0.16) decreased, and average birth order (β, -
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0.0007; 95% CI, -0.0009, -0.0005) and %poverty (β, -0.022; 95% CI, -0.026, -0.017) 
remained relatively stable. Though there was an overall decrease in average birthweight 
between 1975 and 2013, a steady increase in average birthweight occurred in earlier years 
before reversing direction in the late 1980s (linear β, 4.26; 95% CI, 4.00, 4.52; quadratic 
β, -0.17; 95% CI, -0.18, -0.17). Several county-level characteristics were highly 
correlated (Table 2-2), though standard errors remained stable in fully adjusted models. 
We present associations between county-level characteristics and combined 
childhood cancer incidence in Table 2-3. After adjusting for year of diagnosis, county-
level average maternal age (rate ratio (RR), 1.22; 95% CI, 1.11, 1.34), average 
birthweight (RR, 1.57; 95% CI, 1.37, 1.80), and %white (RR, 1.03; 95% CI, 1.01, 1.04) 
were positively associated with county-level incidence of combined childhood cancers 
over the 39-year study period. County-level average birth order (RR, 0.86; 95% CI, 0.76, 
0.97), %Hispanic (RR, 0.97; 95% CI, 0.95, 0.98), and %poverty (RR, 0.87; 95% CI, 0.83, 
0.90) were inversely associated with county-level combined childhood cancer incidence. 
However, associations between county-level characteristics and combined childhood 
cancer incidence were attenuated towards the null, and no longer statistically significant, 
in fully adjusted models. Similar patterns of association were observed among individual 
childhood cancers, though to varying magnitudes and with some differences in 
directionality (Table 2-4). For example, %Hispanic was positively associated with 
incidence of ALL (fully adjusted RR, 1.05; 95% CI, 1.02, 1.08).  
As illustrated in Figure 2-2, the incidence of combined childhood cancers 
significantly increased between 1975 and 2013 at an AAPC of 0.71% per year (95% CI, 
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0.55, 0.86). Between 1975 and 2013, a statistically significant increase in incidence was 
also observed for ALL (AAPC, 0.78%; 95% CI, 0.49, 1.07), AML (1.86%; 1.13, 2.59), 
CNS tumors (1.31%; 0.94, 1.67), and hepatoblastoma (2.70%; 1.68, 3.72). There was no 
statistically significant change over time in incidence of neuroblastoma (AAPC, 0.28%; 
95% CI, -0.12, 0.68), retinoblastoma (0.25%; 95% CI, -0.38, 0.88), or Wilms’ tumor (-
0.15%; 95% CI, -0.65, 0.36).  
In Table 2-5, we compare crude and adjusted AAPCs in incidence of childhood 
cancers with significant temporal trends (combined, ALL, AML, CNS tumors, and 
hepatoblastoma). Across all the county-level characteristics and all the cancers tested, the 
most notable reduction in AAPC in cancer incidence occurred after adjustment for county 
trends in maternal age. Adjustment for county-level average maternal age reduced the 
AAPC in incidence of combined childhood cancers to 0.32% per year (95% CI, 0.08, 
0.56), a 55% reduction from the crude AAPC, and reduced AAPCs in incidence of 
individual cancers by between 8% for hepatoblastoma to 40% for ALL. However, even 
after adjustment for maternal age, AAPCs in county-level cancer incidence remained 
significant from zero. Adjustment for other county-level characteristics either had no 
effect on county-level cancer incidence rates over time (e.g. birth order), or increased the 
AAPC, suggesting a masking effect. For example, adjustment for county-level average 
birthweight increased the AAPC in combined childhood cancer incidence by 21% from 
the crude (adjusted AAPC, 0.86; 95% CI, 0.69, 1.02). 
AAPCs in incidence of combined and individual childhood cancers remained 
statistically significantly above 0% in models fully adjusted for all county-level 
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characteristics, with only an attenuation towards the null observed for AML (adjusted 
AAPC, 1.62%; 95% CI, 0.38, 2.87; 13% reduction) and hepatoblastoma (2.36%; 95% CI, 
0.71, 4.04; 12%). Fully adjusted AAPCs increased from the crude for combined 
childhood cancers (0.75%; 95% CI, 0.48, 1.03; 6% increase), ALL (0.81%; 95% CI, 0.31, 
1.31; 4%), and CNS tumors (1.69%; 95% CI, 1.03, 2.35; 29%). 
Discussion 
This is the first study to test temporal associations between pregnancy-related risk 
factors and cancer incidence rates in the US pediatric population. Through the use of 
linked population-based registry data over almost four decades, we confirmed that the 
combined cancer incidence rate among children, 0 to 4 years of age, has been gradually 
increasing in the United States by about 0.7% per year since 1975.2 We also confirmed 
increasing trends in incidence rates of ALL, AML, CNS tumors, and hepatoblastoma.67 
For these cancers, we tested whether temporal trends in select county-level characteristics 
were associated with rising incidence rates.  
We found preliminary evidence of a temporal association between county-level 
average maternal age and childhood cancer incidence rates. Descriptive analysis revealed 
that, of all the county-level characteristics assessed, the temporal trend in county-level 
average maternal age most closely aligns with trends in childhood cancer incidence rates. 
Specifically, we showed that county-level average maternal age has been steadily 
increasing in the United States at an annual rate of about 0.07 years since 1975 (Figure 2-
1). Further, we found that estimated AAPCs in incidence of combined and individual 
childhood cancers were substantially attenuated towards the null in models adjusted only 
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for maternal age, with a reduction from the crude of between 8% for hepatoblastoma to 
55% for combined childhood cancers (Table 2-5). However, we note that AAPCs 
adjusted only for maternal age remained significantly above the null value of 0% change. 
Further, AAPCs estimated from fully adjusted models indicated a much weaker temporal 
association between maternal age and childhood cancer incidence.  
Besides maternal age, we found no evidence that other county-level 
characteristics including birthweight, birth order, and sociodemographic factors, are 
associated with rising childhood cancer incidence rates over time. Adjustment for these 
factors resulted in an estimated AAPC in childhood cancer incidence that was either 
higher than or no different than the crude. This suggests that, if anything, trends in these 
county-level characteristics counteract rising childhood cancer incidence rates over time 
in the United States.  
Contrary to our study hypothesis, estimated AAPCs in incidence rates of 
combined and individual childhood cancers remained significantly above 0% after 
comprehensive adjustment for county-level sociodemographic and pregnancy-related 
characteristics. In fact, only the fully adjusted AAPCs for AML and hepatoblastoma were 
attenuated towards the null; all other fully adjusted AAPCs were higher than the crude 
(combined, ALL, CNS tumors). While individual-level associations between maternal 
age and AML have been previously documented in the literature, there is currently little 
evidence of an association between maternal age and hepatoblastoma risk.24 Therefore, 
the observed reduction in the hepatoblastoma incidence trend attributed to maternal age 
should be interpreted with caution, especially given small case counts.   
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Limitations 
There are several limitations to our analysis. First, as with any ecologic study, 
group-level risk factors may not be associated with incidence at the individual-level.61 
This is especially true for larger counties in which greater heterogeneity in pregnancy-
related and sociodemographic characteristics is expected. To assess this limitation, we 
conducted a sensitivity analysis in which we estimated crude and adjusted AAPCs in 
incidence of combined childhood cancers within subsets of our sample restricted to (1) 
counties of <10,000 children (averaged over 1975-2013), (2) counties of <5,000 children, 
and (3) counties of <1,000 children. This revealed that maternal age accounted for a 
much greater portion of the annual trend in combined childhood cancer incidence for 
smaller counties than what we observed in our analysis of all counties with available data 
(Table 2-6). This is consistent with results we would expect from measurement error of 
area-level maternal age, which could be higher in larger counties (given larger variation), 
that serves to minimize the percent reduction after adjustment. However, we note that 
estimates lost precision upon restriction to smaller counties.   
Second, because county of birth is not available in SEER, we made the 
assumption that county of residence was stable from birth to diagnosis. To minimize 
potential bias due to this assumption, we restricted our sample to younger children, ages 0 
to 4 years, given that residential mobility increases with age.112 We acknowledge that a 
California-based study reported that 38.5% of leukemia cases, ages 0 to 4 years, had 
moved away from county of birth by time of diagnosis, indicating that residential 
mobility is relatively common among younger children, at least in California.112 
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Nevertheless, this study found no significant differences in sociodemographic 
characteristics of counties at birth and diagnosis among residentially mobile cases.112 
Further, a recent case-cohort study in Minnesota reported high correlation between the 
socioeconomic status of residential census tracts at birth and diagnosis among cancer 
cases, ages 0 to 14 years.115 Therefore, even if our assumption of stable residency is 
incorrect, it may be appropriate to assume stable county-level characteristics throughout 
early childhood.  
Third, there were limitations to our measures of county-level characteristics. For 
example, our measure of county-level poverty was not specific to the early childhood 
population (0 to 4 years). We also did not consider all potential pregnancy-related risk 
factors, such as paternal age, due to issues of missing data and potential collinearity.24 
Further, we note potential concerns of a few strong correlations among county-level 
characteristics (Table 2-2), which may have hindered our ability to fully disentangle 
associations, especially in ecologic data.61 To further tease apart county-level 
characteristics, we conducted a sensitivity analysis in which we tested temporal 
associations between pregnancy-related risk factors and cancer incidence among only 
white children within counties, which produced similar overall patterns (Table 2-7).  
Finally, this study was limited by sample size, both in terms of observational units 
(N=194 counties) and small case counts within counties. The rarity of childhood cancers 
required us to combine all diagnoses among ages 0 and 4 years into a single rate, which 
resulted in less precise exposure measures aggregated over the six-year birth window.  
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Given the noted limitations of our study, further time series research is needed in 
larger analytic samples, and using more robust data, to confirm temporal associations 
between pregnancy-related risk factors and childhood cancer incidence rates. For 
example, future studies should test temporal associations in data aggregated over smaller 
observational units, such as at the census tract-level. Studies should also employ birth and 
cancer registry data linked at the individual-level to address such questions as whether 
cancer incidence rates have increased over time when restricted to children born to older 
mothers (e.g. > 35 years). We emphasize the need for thorough covariate control in future 
time series research. This is underscored by the fact that we only identified significant 
temporal associations between maternal age and childhood cancer incidence in minimally 
adjusted models, and that the one prior study to report a significant temporal association 
between maternal age and ALL incidence did not adjust for potential confounders.77 
Conclusion 
Overall, we did not find conclusive evidence to support our hypothesis that the 
rise in pregnancy-related risk factors accounts for the documented rise in childhood 
cancer incidence over time. While preliminary findings suggested an association between 
rising maternal age and childhood cancer incidence over time, comprehensive adjustment 
for all county-level characteristics had little impact on estimated incidence trends in 
combined and individual childhood cancers. Therefore, we cannot rule out alternative 
explanations for increasing trends, including the possibility that rising incidence rates are 
an artifact of changes over time in diagnostic technology, disease classification, and 
registry completeness. We also cannot rule out the possibility that rising childhood cancer 
 28 
 
incidence rates may be attributed to changes over time in other risk factors. For example, 
it has been hypothesized that environmental exposures, such as low-level radiation, may 
contribute to the rise in childhood cancer incidence over time.71-73 However, there is 
currently little evidence linking such exogenous exposures to childhood cancer risk,3 and 
levels of some environmental pollutants may have actually decreased in the United States 
during our study period.74 Moreover, although exposure to environmental hazards is 
generally greater among African American children,64 their rate of ALL and many solid 
tumors is substantially lower than among white children.67 Therefore, the rise in 
childhood cancer incidence rates remains a topic of debate in the literature, and thus 
further time series research is needed that can build upon our findings and ultimately 
pinpoint the underlying cause of temporal trends.  
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Table 2-1 County-level pregnancy-related and sociodemographic characteristics of SEER 9 counties (N=194) 
 
1975-1980 
 
2008-2013 
County-Level Characteristic Mean Std 25th Pct Median 75th Pct   Mean Std 25th Pct Median 75th Pct 
Average Maternal Age (years) 24.8 0.7 24.3 24.7 25.1  27.0 1.4 26.2 26.9 27.6 
Average Birthweight (grams) 3,361 102 3,312 3,388 3,434  3,300 89 3,238 3,320 3,366 
Average Live Birth Order 2.2 0.3 2.0 2.1 2.4  2.2 0.2 2.1 2.1 2.3 
% White 95.0 10.5 95.6 98.8 99.5  89.4 13.3 87.0 94.5 97.1 
% Hispanic 9.8 19.0 0.4 1.5 5.1  19.2 21.2 4.5 10.8 24.0 
% Poverty 13.5 6.4 9.4 12.1 15.3  13.5 5.1 9.9 12.5 16.2 
Notes: Std = standard deviation; Pct =percentile. 
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Figure 2-1 Temporal trends in county-level characteristics, SEER 9 counties (N=194), 1975-2013 
 
 a. County-Level Average Maternal Age              b. County-Level Average Birthweight                 c. County-Level Average Birth Order 
   
 
 d. County-Level Proportion White                           e. County-Level Proportion Hispanic                      f. County-Level Proportion Poverty 
   
Notes: Annual county-level estimates are averaged across the sample of 194 counties (i.e. points represent the annual average of county-level averages). Time beta coefficients (β) 
and 95% confidence intervals (CI) estimated from linear mixed models specifying year of diagnosis predicting specified county-level characteristic. County-level proportion white 
and proportion Hispanic refer to the childhood population, ages 0-4 years, within counties. County-level proportion poverty refers to the entire population, all ages, within counties 
below the poverty line.
linear time: β = 0.068, 95% CI = (0.067, 0.070)  linear time: β = 4.26, 95% CI = (4.00, 4.52) 
quadratic time: β = -0.17, 95% CI = (-0.18, -0.17) 
 
linear time: β = -0.0007, 95% CI = (-0.0009, -0.0005)  
linear time: β = -0.17, 95% CI = (-0.17, -0.16)  linear time: β = 0.30, 95% CI = (0.29, 0.30)  linear time: β = -0.022, 95% CI = (-0.026, -0.017)  
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Table 2-2 Correlation matrix of county-level characteristics, SEER 9 counties 
(N=194), 1975-2013 
  Pearson Correlations 
VIF   1 2 3 4 5 6 7 
1. Year of Diagnosis 1             1.84 
2. Maternal Age 0.57 1           2.25 
3. Birthweight -0.27 0.13 1         2.66 
4. Birth Order -0.03 -0.12 -0.16 1       1.37 
5. % White -0.15 -0.17 0.34 0.07 1     1.52 
6. % Hispanic 0.16 -0.21 -0.69 -0.08 -0.14 1   3.07 
7. % Poverty -0.04 -0.43 -0.49 0.24 -0.28 0.61 1 2.56 
Notes: VIF = variance inflation factor. 
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Table 2-3 Associations between county-level characteristics and combined childhood 
cancer incidence, ages 0 to 4 years, SEER 9 counties (N=194), 1975-2013 
County-Level Characteristic 
Adjusted Only for               
Year of Diagnosis  
Fully Adjusted for  
All Characteristics 
RR 95% CI P   RR 95% CI P 
Maternal Age (per 5-year increase) 1.22 (1.11, 1.34) <.001  1.08 (0.97, 1.20) .14 
Birthweight (per 500-gram increase) 1.57 (1.37, 1.80) <.001  1.17 (0.97, 1.41) .10 
Birth Order (per 1-unit increase) 0.86 (0.76, 0.97) .015  0.93 (0.83, 1.05) .26 
% White (per 10% increase) 1.03 (1.01, 1.04) .002  1.02 (1.00, 1.03) .079 
% Hispanic (per 10% increase)  0.97 (0.95, 0.98) <.001  0.98 (0.97, 1.00) .081 
% Poverty (per 10% increase) 0.87 (0.83, 0.90) <.001   0.95 (0.89, 1.02) .16 
Notes: Rate ratios (RR) and 95% confidence intervals (CI) estimated from Poisson mixed models with a random 
intercept for repeated county-level measures over time. Fully adjusted models control for year of diagnosis and all 
county-level characteristics simultaneously. 
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Table 2-4 Associations between county-level characteristics and childhood cancer 
incidence, ages 0 to 4 years, by cancer type, SEER 9 counties (N=194), 1975-2013 
County-Level 
Characteristic 
Combined Cancers Acute Lymphoblastic Leukemia 
Adjusted for Year   
of Diagnosis 
Fully Adjusted for 
All Characteristics 
Adjusted for Year    
of Diagnosis 
Fully Adjusted for   
All Characteristics 
RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Maternal Age 1.22 (1.11, 1.34) 1.08 (0.97, 1.20) 1.17 (0.99, 1.39) 1.03 (0.85, 1.25) 
Birthweight 1.57 (1.37, 1.80) 1.17 (0.97, 1.41) 1.53 (1.15, 2.02) 1.37 (0.97, 1.91) 
Birth Order 0.86 (0.76, 0.97) 0.93 (0.83, 1.05) 0.82 (0.67, 1.02) 0.90 (0.73, 1.11) 
% White 1.03 (1.01, 1.04) 1.02 (1.00, 1.03) 1.06 (1.03, 1.09) 1.04 (1.01, 1.07) 
% Hispanic 0.97 (0.95, 0.98) 0.98 (0.97, 1.00) 1.01 (0.99, 1.04) 1.05 (1.02, 1.08) 
% Poverty 0.87 (0.83, 0.90) 0.95 (0.89, 1.02) 0.87 (0.80, 0.95) 0.92 (0.82, 1.03) 
County-Level 
Characteristic 
Acute Myeloid Leukemia CNS Tumors 
RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Maternal Age 1.22 (0.85, 1.74) 1.34 (0.85, 2.11) 1.15 (0.96, 1.39) 0.98 (0.76, 1.26) 
Birthweight 1.25 (0.68, 2.30) 0.91 (0.40, 2.06) 2.11 (1.55, 2.87) 1.65 (1.04, 2.60) 
Birth Order 1.16 (0.78, 1.74) 1.21 (0.72, 2.03) 0.94 (0.74, 1.20) 1.11 (0.84, 1.45) 
% White 0.99 (0.94, 1.03) 1.00 (0.93, 1.07) 1.05 (1.02, 1.08) 1.01 (0.97, 1.05) 
% Hispanic 0.91 (0.85, 0.97) 0.90 (0.84, 0.97) 0.95 (0.92, 0.99) 0.99 (0.95, 1.03) 
% Poverty 0.96 (0.79, 1.16) 1.08 (0.82, 1.43) 0.82 (0.74, 0.91) 0.90 (0.77, 1.06) 
County-Level 
Characteristic 
Neuroblastoma Retinoblastoma 
RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Maternal Age 1.47 (1.22, 1.77) 1.16 (0.89, 1.52) 1.04 (0.79, 1.37) 1.06 (0.70, 1.59) 
Birthweight 1.83 (1.32, 2.55) 1.07 (0.67, 1.70) 0.98 (0.63, 1.54) 0.91 (0.44, 1.87) 
Birth Order 0.67 (0.53, 0.85) 0.81 (0.60, 1.10) 0.78 (0.54, 1.11) 0.62 (0.38, 1.00) 
% White 1.01 (0.98, 1.04) 1.00 (0.96, 1.04) 0.98 (0.94, 1.01) 1.01 (0.95, 1.08) 
% Hispanic 0.93 (0.89, 0.96) 0.94 (0.90, 0.98) 0.96 (0.91, 1.01) 0.94 (0.88, 1.00) 
% Poverty 0.78 (0.70, 0.87) 0.90 (0.76, 1.07) 1.04 (0.91, 1.20) 1.20 (0.94, 1.53) 
County-Level 
Characteristic 
Wilms' Tumor Hepatoblastoma 
RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Maternal Age 1.35 (1.04, 1.75) 1.14 (0.81, 1.62) 1.12 (0.75, 1.67) 1.16 (0.63, 2.14) 
Birthweight 1.61 (1.06, 2.46) 1.31 (0.70, 2.43) 1.52 (0.74, 3.10) 1.91 (0.65, 5.67) 
Birth Order 0.93 (0.68, 1.28) 1.15 (0.79,1.68) 1.09 (0.64, 1.88) 1.43 (0.71, 2.90) 
% White 1.00 (0.96, 1.04) 0.97 (0.92, 1.03) 1.03 (0.97, 1.09) 1.00 (0.90, 1.10) 
% Hispanic 0.93 (0.88, 0.98) 0.95 (0.90, 1.01) 1.03 (0.96, 1.10) 1.06 (0.97, 1.16) 
% Poverty 0.85 (0.74, 0.97) 0.90 (0.73, 1.12) 0.95 (0.76, 1.19) 1.00 (0.69, 1.46) 
Notes: Rate ratios (RR) and 95% confidence intervals (CI) estimated from Poisson mixed models with a random 
intercept for repeated county-level measures over time. RR estimates a 5-year change in maternal age, 500-gram 
change in birthweight, 1-unit change in birth order, and 10% change in proportion white, Hispanic, and below the 
poverty line. Fully adjusted models control for year of diagnosis and all county-level characteristics simultaneously. 
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Figure 2-2 Temporal trends in childhood cancer incidence rates, ages 0 to 4 years, 
SEER 9 counties (N=194), 1975-2013 
 
 a. Combined Childhood Cancers                            b. Acute Lymphoblastic Leukemia 
    
 c. Acute Myeloid Leukemia                                    d. Central Nervous System Tumors  
     
 e. Hepatoblastoma                                                   f. Neuroblastoma 
     
 g. Retinoblastoma                                                    h. Wilms’ Tumor 
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Notes: Annual incidence rates represent the cancer incidence rate among children, ages 0 to 4 years, within all 194 
counties. Average annual percent change (AAPC) estimated from Poisson mixed models with a random intercept for 
repeated county-level measures over time. 
AAPC = 0.71% (0.55, 0.86) AAPC = 0.78% (0.49, 1.07) 
AAPC = 1.86% (1.13, 2.59) AAPC = 1.31% (0.94, 1.67) 
AAPC = 2.70% (1.68, 3.72) AAPC = 0.28% (-0.12, 0.68) 
AAPC = 0.25% (-0.38, 0.88) AAPC = -0.15% (-0.65, 0.36) 
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Table 2-5 Crude and adjusted average annual percent change (AAPC) in childhood cancer incidence rates, ages 0 to 4 years, 
SEER 9 counties (N=194), 1975-2013 
 Combined Cancers  ALL  AML  CNS   HB 
Model AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change 
Crude 0.71 (0.55, 0.86)   0.78 (0.49, 1.07)   1.86 (1.13, 2.59)   1.31 (0.94, 1.67)   2.70 (1.68, 3.72)  
individually adjusted for:                  
Maternal Age 0.32 (0.08, 0.56) -55%  0.47 (0.02, 0.91) -40%  1.48 (0.47, 2.49) -20%  1.02 (0.50, 1.55) -22%  2.48 (1.19, 3.78) -8% 
Birthweight 0.86 (0.69, 1.02) 21%  0.92 (0.61, 1.23) 18%  1.94 (1.17, 2.72) 4%  1.56 (1.18, 1.95) 20%  2.85 (1.80, 3.92) 6% 
Birth Order 0.71 (0.55, 0.86) 0%  0.77 (0.48, 1.06) 0%  1.86 (1.12, 2.59) 0%  1.31 (0.94, 1.67) 0%  2.70 (1.68, 3.72) 0% 
% White 0.80 (0.63, 0.96) 12%  0.98 (0.68, 1.28) 26%  1.80 (1.05, 2.56) -3%  1.47 (1.09, 1.85) 12%  2.79 (1.76, 3.83) 3% 
% Hispanic 0.86 (0.69, 1.03) 21%  0.72 (0.40, 1.03) -8%  2.28 (1.49, 3.08) 23%  1.51 (1.11, 1.91) 15%  2.57 (1.50, 3.65) -5% 
% Poverty 0.83 (0.67, 0.99) 17%  0.89 (0.59, 1.19) 15%  1.90 (1.14, 2.66) 2%  1.47 (1.09, 1.85) 12%  2.74 (1.71, 3.78) 2% 
Fully Adjusted 0.75 (0.48, 1.03)           6%   0.81 (0.31, 1.31) 4%   1.62 (0.38, 2.87) -13%   1.69 (1.03, 2.35) 29%   2.36 (0.71, 4.04) -12% 
Notes: Average annual percent change (AAPC) estimated from Poisson mixed models with a random intercept for repeated county-level measures over time. Crude models specify 
year of diagnosis predicting county incidence rates. Individually adjusted models further specify each county-level characteristic, modeled one at a time. Fully adjusted models 
specify year of diagnosis and all county-level characteristics simultaneously. The % change compares crude to adjusted AAPCs. ALL = acute lymphoblastic leukemia; AML = 
acute myeloid leukemia; CNS = combined central nervous system tumors; HB = hepatoblastoma. 
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Table 2-6 Sensitivity analysis by county size: crude and adjusted average annual percent change (AAPC) in childhood cancer 
incidence rates, ages 0 to 4 years, SEER 9 counties (N=194), 1975-2013 
  
Entire Sample              
(N=194)  
Population < 10,000 
(N=162)  
Population < 5,000  
(N=144)  
Population < 1,000            
(N=70) 
Model   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change 
Crude  0.71 (0.55, 0.86) 
 
 0.69 (0.34, 1.03)   0.53 (0.09, 0.98) 
 
 0.83 (-0.15, 1.82)  
individually adjusted for:              
Maternal Age  0.32 (0.08, 0.56) -55%  0.18 (-0.26, 0.63) -73%  0.03 (-0.54, 0.60) -94%  0.06 (-1.21, 1.34) -93% 
Birthweight  0.86 (0.69, 1.02) 21%  0.88 (0.52, 1.25) 28%  0.73 (0.25, 1.21) 36%  1.00 (-0.05, 2.07) 21% 
Birth Order  0.71 (0.55, 0.86) 0%  0.68 (0.34, 1.03) -1%  0.53 (0.09, 0.98) 0%  0.78 (-0.20, 1.77) -6% 
% White  0.80 (0.63, 0.96) 12%  0.80 (0.45, 1.15) 16%  0.60 (0.14, 1.07) 13%  0.75 (-0.41, 1.92) -10% 
% Hispanic  0.86 (0.69, 1.03) 21%  0.84 (0.48, 1.19) 21%  0.67 (0.22, 1.13) 26%  0.95 (-0.04, 1.95) 14% 
% Poverty  0.83 (0.67, 0.99) 17%  0.72 (0.37, 1.06) 4%  0.53 (0.09, 0.97) -1%  0.74 (-0.26, 1.75) -11% 
Fully Adjusted   0.75  (0.48, 1.03) 6%     0.58 (0.08, 1.08)  -16%     0.31 (-0.39, 1.01)   -42%   -0.41  (-2.12, 1.33)  -150%  
Notes: Average annual percent change (AAPC) estimated from Poisson mixed models with a random intercept for repeated county-level measures over time. Crude models specify 
year of diagnosis predicting county incidence rates. Individually adjusted models further specify each county-level characteristic, modeled one at a time. Fully adjusted models 
specify year of diagnosis and all county-level characteristics simultaneously. The % change compares crude to adjusted AAPCs.  
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Table 2-7 Sensitivity analysis restricted to white children: crude and adjusted average annual percent change (AAPC) in 
childhood cancer incidence rates, ages 0 to 4 years, SEER 9 counties (N=194), 1975-2013 
 Combined Cancers  ALL  AML  CNS   HB 
Model AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change   AAPC 95% CI %change 
Crude 0.73 (0.56, 0.90)   0.97 (0.66, 1.28)   1.52 (0.70, 2.35)   1.35 (0.95, 1.75)   2.83 (1.69, 3.98)  
individually adjusted for:                  
Maternal Age 0.38 (0.14, 0.62) -48%  0.81 (0.39, 1.23) -16%  1.19 (0.09, 2.30) -22%  1.19 (0.66, 1.72) -12%  2.50 (1.09, 3.92) -12% 
Birthweight 0.83 (0.65, 1.01) 14%  1.00 (0.67, 1.32) 3%  1.71 (0.84, 2.58) 12%  1.52 (1.10, 1.94) 12%  2.92 (1.73, 4.13) 3% 
Birth Order 0.73 (0.56, 0.90) 0%  0.97 (0.66, 1.28) 0%  1.52 (0.70, 2.35) 0%  1.35 (0.95, 1.75) 0%  2.83 (1.69, 3.99) 0% 
Fully Adjusted 0.61 (0.34, 0.88) -16%   0.93 (0.44, 1.42) -4%   1.40 (0.13, 2.69) -8%   1.54 (0.91, 2.18) 14%   2.54 (0.88, 4.23) -10% 
Notes: Average annual percent change (AAPC) estimated from Poisson mixed models with a random intercept for repeated county-level measures over time. Crude models specify 
year of diagnosis predicting county incidence rates. Individually adjusted models further specify each county-level characteristic, modeled one at a time. Fully adjusted models 
specify year of diagnosis and all county-level characteristics simultaneously.  The % change compares crude to adjusted AAPCs.  ALL = acute lymphoblastic leukemia; AML = 
acute myeloid leukemia; CNS = combined central nervous system tumors; HB = hepatoblastoma.  
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Manuscript 2: Socioeconomic status and childhood cancer 
incidence: a population-based multilevel analysis 
Introduction 
Socioeconomic status (SES) is consistently linked to a range of health outcomes 
in children and adults including many adulthood cancers.44-46 SES may also be associated 
with childhood cancer incidence operating through various mechanisms at both the 
individual and area levels. Individual-level SES may influence incidence through 
mediators such as parental occupational exposures, dietary patterns, infectious agents, 
family reproductive decisions such as maternal age and family size, and birth outcomes 
such as birthweight.3,63 SES may also operate as a mediator of other preceding 
demographic social determinants of health including foreign birthplace or 
race/ethnicity.3,60 For example, a recent study reported lower risk of several cancers 
among Hispanic children of foreign born compared to US born mothers.60 Area-level 
SES may independently influence risk through mediators such as environmental 
pollutants and toxins, infectious agents, and social norms regarding lifestyle 
behaviors.50,64 Thus, in-depth knowledge of the association between SES and childhood 
cancer risk may provide etiologic insight into the role of environmental and behavioral 
exposures, particularly since the causes of childhood cancer are not well understood.  
Empirical evidence of an association between SES and childhood cancer 
incidence remains limited and inconclusive. While ecologic findings from international 
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and within-country small area studies suggest an adverse association between higher SES 
and incidence of some childhood cancers,50-54 individual-level studies largely report null 
associations.43,55-59 However, there are several limitations to previous work conducted at 
the individual-level. First, studies have predominantly focused on childhood leukemia 
due to its higher incidence and suspected infectious etiology.13,47,48 Given that different 
cancers likely have different etiologies,5 it is important to investigate associations of SES 
with other non-leukemic cancers. Second, a case-control design is commonly used to test 
associations due to the rarity of childhood cancers. Because controls in studies requiring 
active participation tend to be higher SES than the source population of interest,116 
participation-based case-control studies can produce biased estimators. Third, established 
risk factors associated with SES, such as birthweight and maternal age,3 have not been 
consistently controlled for across studies. This hinders cross-study comparisons and 
potentially obscures underlying mechanisms contributing to an SES association. Finally, 
no study, to our knowledge, has used multilevel methods to test for independent 
associations of SES at the individual and small area levels. Without a multilevel 
approach, it is possible that SES at one level is merely a proxy for SES at the other level, 
thus masking etiology. In this study, we addressed these limitations by leveraging registry 
data in a population-based case-cohort study. We assessed SES at both the individual and 
neighborhood level and accounted for established risk factors that may confound or 
mediate associations of SES and childhood cancer incidence. 
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Methods 
Study Population 
We ascertained cases, diagnosed ages 0 to 14 years, from the Minnesota Cancer 
Surveillance System (MCSS), which is estimated to have 99.7% cancer case 
completeness and 96.5% overall data accuracy.117 We restricted our sample to cases born 
between 1989 (when residential addresses were first recorded on birth certificates) and 
2014, with a linked Minnesota birth record (86%). Records were linked based on first and 
last name, date of birth, and social security number (when available) through probabilistic 
record linkage using LinkPlus software.118,119 We then implemented a case-cohort study 
design in which we randomly sampled four controls per case, frequency matched on birth 
year, from the Minnesota birth registry without regard to case status.120 To rule out 
children with higher penetrance genetic syndromes,121,122 we excluded 20 cases and 5 
controls with Down syndrome and 11 cases with multiple primary tumors, resulting in a 
final analytic sample of 2,947 cases and 11,907 controls (N=14,854).  
Outcome 
We assessed incidence of combined (all diagnoses) and individual childhood 
cancers based on the International Classification of Childhood Cancer, third edition.113 
We assessed incidence of acute lymphoblastic leukemia (ALL), acute myeloid leukemia 
(AML), lymphomas, central nervous system (CNS) tumors, neuroblastoma, 
retinoblastoma, Wilms’ tumor, hepatoblastoma, and rhabdomyosarcoma. Bone sarcomas 
and germ cell tumors were not assessed individually because these cancers are most 
common in adolescents. 
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Measures of SES 
Individual-level SES – We used maternal education to measure individual-level 
SES. The validity of using maternal education as a measure of childhood SES has been 
demonstrated previously,123,124 and is commonly used as a reliable measure of SES in US 
birth registry studies.125 Between 1989 and 2010, maternal education was recorded on 
birth certificates as years of schooling, ranging from 0 to 17. Beginning in 2011, 
education was recorded as highest degree earned, ranging from (1) 8th grade or less to (8) 
doctorate or professional degree. We grouped education into four categories to ensure 
sufficient sample size and consistency across years: (1) < 12 years of schooling or less 
than high school diploma, (2) 12 years of schooling or high school diploma, (3) 13-15 
years of schooling or some college or associates degree, and (4) 16+ years of schooling or 
bachelor’s degree or higher. After confirming linearity (Figure 3-1, Panel A), we 
modeled education ordinally.  
Neighborhood-level SES – Residential addresses were abstracted from birth 
records and geocoded to census tracts using normalized 2010 geographic boundaries.126 
We created a SES index derived from the first component score from a nationwide 
principal components analysis (PCA)127 of 5 tract-level US Census variables: % poverty, 
% on welfare or public assistance, % of those aged 16+ unemployed, % female headed 
households with children, and % of those aged 25+ with less than a high school 
education.128,129 A separate PCA was performed for each decade (1980 to 2010) using 
decennial census data, 1980-2000, and American Community Survey (ACS) data, 2005-
2009, for 2010. We assigned values based on year of birth and linearly interpolated SES 
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scores for intercensal years. High internal consistency was observed for each decade of 
data (Cronbach’s alpha range: .89–.92).129 We confirmed linearity (Figure 3-1, Panel B) 
and standardized scores so that a one-unit change equates to one standard deviation; 
higher index values indicate higher neighborhood SES.  
Statistical Analysis  
We compared demographic, socioeconomic, and birth characteristics of cases and 
controls using Pearson’s chi-square test for categorical measures and the two-sample t-
test for continuous measures. To untangle associations of SES and cancer incidence 
(combined and by individual type), we tested logistic mixed models with a random 
intercept for clustering within census tracts. Intraclass correlations (ICC) estimated from 
unimputed bivariate logistic mixed models revealed minimal tract-level clustering across 
cancer types (ICC <0.08) except rhabdomyosarcoma (ICC = 0.29), though ICCs for rare 
outcomes may be unreliable.130 We tested two sets of models, one specifying maternal 
education as the primary predictor (“A” models), the other specifying neighborhood SES 
as the primary predictor (“B” models). Model 1 tested bivariate (crude) associations 
between SES and cancer incidence. Model 2 tested these associations adjusted for 
maternal race/ethnicity (non-Hispanic white versus otherwise). Model 3 further adjusted 
for pregnancy-related factors previously associated with childhood cancer risk including 
maternal age (years),3,24 birthweight (grams; values <350 grams considered implausible 
and recoded to missing),3,111 gestational age (weeks; values <20 or >45 weeks considered 
implausible and recoded to missing),3,28 birth order (first born versus higher),3,29 birth 
year,3 and sex.3 Model 4 tested the independent association of SES at each level of 
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exposure by simultaneously fitting models with both maternal education and 
neighborhood SES, along with previously specified covariates.   
To further characterize the utility of covariate adjustment in studies of childhood 
cancer etiology, we tested additional models probing associations of SES and established 
risk factors. First, for cancers in which covariate adjustment attenuated SES effect 
estimates, we tested trivariate models of SES predicting cancer incidence, adjusting for 
each covariate, previously specified in Model 3, one at a time. We then calculated the 
percent change in estimated SES-cancer incidence associations between bivariate (Model 
1) and trivariate models (% change = (βbivar – βtrivar)/ βbivar). Second, to assess the utility of 
adjusting for SES in prediction models, we compared effect estimates of race/ethnicity, 
maternal age, birthweight, gestational age, and birth order from fully adjusted models 
(Model 4) to estimates from models specifying all covariates expect the two SES 
measures (Model 5). We used multiple imputation by chained equations to impute 
missing data.131 Statistical significance was determined as p < .05 for a 2-sided 
hypothesis test. Multiple imputation and analyses were performed using Stata 14.2 
(College Station, TX).114  
Results 
Descriptive characteristics of cases and controls are compared in Table 3-1. Cases 
were more likely to be male, higher birthweight, and exhibited slightly shorter gestation 
compared to controls. Mothers of cases were older, had higher education levels, and were 
more likely to be non-Hispanic white than controls. Cases had higher neighborhood SES 
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than controls. The two SES measures displayed moderate correlation (Spearman ρ=0.35). 
Additional variable correlations are available in Table 3-2. 
In Table 3-3, we present associations of maternal education and childhood cancer 
incidence. In crude Model 1A, a one-step increase in maternal education (e.g. from high 
school graduate to some college) was associated with an 8% increase in risk of combined 
childhood cancers (OR, 1.08; 95% CI, 1.04, 1.13; p <.001). Statistically significant crude 
adverse associations with higher maternal education were also observed for ALL (OR, 
1.10; 95% CI, 1.02, 1.19, p = .018), CNS tumors (OR, 1.12; 95% CI, 1.04, 1.21; p = 
.005), and neuroblastoma (OR, 1.15; 95% CI, 1.02, 1.30, p = .028). Crude associations 
were elevated and marginally statistically significant, for lymphomas (OR, 1.11; 95% CI, 
0.99, 1.25; p = .066) and Wilms’ tumor (OR, 1.15; 95% CI, 1.00, 1.32; p = .057). After 
adjusting for race/ethnicity (Model 2A) and pregnancy-related risk factors (Model 3A), 
adverse associations of higher SES were attenuated towards the null and no longer 
statistically significant. Further adjustment for neighborhood SES (Model 4A) did not 
substantively alter non-significant estimates. An elevated odds ratio was observed for 
maternal education predicting retinoblastoma incidence, though confidence intervals 
were wide (e.g. Model 4A: OR, 1.25; 95% CI, 0.94, 1.65; p = .12).  
Conversely, we found a statistically significant protective association between 
higher SES and hepatoblastoma incidence. In crude Model 1A, a one-step increase in 
maternal education was associated with a 28% reduced risk of hepatoblastoma (OR, 0.72; 
95% CI, 0.54, 0.94; p = .017). This association was robust to comprehensive covariate 
adjustment (Model 4A: OR, 0.70; 95% CI, 0.51, 0.98; p = .037). A protective, marginally 
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statistically significant, association was also observed between higher maternal education 
and rhabdomyosarcoma incidence (Model 4A: OR, 0.77; 95% CI, 0.59, 1.00; p = .054). 
For cancers substantively impacted by covariate control (combined, ALL, 
lymphomas, CNS tumors, neuroblastoma, Wilms’ tumor), we further investigated which 
of the established risk factors accounted for associations (Table 3-4). Adjustment for 
race/ethnicity reduced the estimated effect of maternal education on cancer incidence by 
more than 10% for combined and individual childhood cancers except lymphomas (6%); 
the largest reductions were observed for combined childhood cancers (30%), Wilms’ 
tumor (46%), and CNS tumors (50%). Adjustment for maternal age reduced the estimated 
maternal education effect by >10% for combined childhood cancers (20%), ALL (18%), 
and lymphomas (20%); adjustment for birthweight reduced the effect by >10% for ALL 
(12%) and Wilms’ tumor (13%); and adjustment for birth year reduced the effect by 
>10% for neuroblastoma (19%). Individual adjustment for gestational age, parity, and sex 
had little impact on maternal education effect estimates.  
 We then evaluated associations between neighborhood SES and childhood cancer 
incidence (Table 3-5). In crude models (Model 1B), higher neighborhood SES was 
adversely associated with incidence of combined childhood cancers (OR, 1.09; 95% CI, 
1.04, 1.14; p <.001), ALL (OR, 1.10; 95% CI, 1.01, 1.20; p = .026), lymphomas (OR, 
1.14; 95% CI, 1.01, 1.30; p = .037), and CNS tumors (OR, 1.18; 95% CI, 1.08, 1.29; p 
<.001). Neighborhood SES was no longer associated with incidence of combined or 
individual cancers in models adjusted for race/ethnicity and pregnancy-related risk 
factors (Models 3B), or in models further adjusted for maternal education (Model 4B). 
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Among cancers impacted by covariate control (combined, ALL, lymphomas, CNS 
tumors), adjustment for race/ethnicity reduced the estimated effect of neighborhood SES 
on cancer incidence by >10% for combined childhood cancers (39%), ALL (18%), and 
CNS tumors (49%); adjustment for maternal age reduced the effect by >10% for 
combined childhood cancers (14%), ALL (15%), and lymphomas (12%); and adjustment 
for birthweight reduced the effect for ALL by 10% (Table 3-6). 
As illustrated in Table 3-7, effect estimates of established demographic and 
pregnancy-related risk factors predicting combined childhood cancer incidence were not 
considerably altered by adjustment for maternal education and neighborhood SES. 
Associations for individual types of childhood cancer are provided in Table 3-8.  
Discussion 
This is the first study to employ multilevel methods to examine associations 
between SES and childhood cancer incidence. We tested associations in a population-
based sample using a registry-based case-cohort study design, thus minimizing multiple 
potential sources of bias. Through our analysis, we generated several findings. First, we 
found that higher SES at both levels (maternal education and census tract composite 
index) was consistently adversely associated with incidence of many childhood cancers 
in crude models. Second, these adverse associations were accounted for by established 
demographic and pregnancy-related risk factors. Third, associations between established 
risk factors and childhood cancer incidence were robust to adjustment for SES. Fourth, 
unlike other cancers, higher individual-level SES was significantly associated with lower 
risk of hepatoblastoma, even after comprehensive control of other cancer risk factors.  
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Higher SES, whether operationalized as maternal education at the individual-level 
or as an area-level index, was associated with higher risk of the most common childhood 
cancers (combined, ALL, lymphomas, and CNS tumors), with a similar pattern emerging 
for both SES measures. However, no statistically significant adverse associations 
between higher SES and incidence of combined or individual childhood cancers 
remained after accounting for established demographic and pregnancy-related risk 
factors. This suggests that crude associations of SES at either level primarily capture 
established risk factors not specified in the model. In particular, non-Hispanic white 
race/ethnicity accounted for a substantial portion of adverse associations of higher SES, 
especially for combined childhood cancers, CNS tumors, and Wilms’ tumor. Older 
maternal age and higher birthweight also explained some of the adverse SES association, 
though to varying degrees across cancer types.  
Further investigation of associations between established risk factors (e.g. 
race/ethnicity and birthweight) and childhood cancer incidence revealed that effect 
estimates were robust to adjustment for SES, suggesting that SES has limited impact on 
incidence of most childhood cancers beyond the social patterning of these exposures. 
Therefore, adjustment for proximal demographic and pregnancy-related risk factors is 
likely sufficient in analyses of childhood cancer etiology. This is reassuring, especially 
given the lack of socioeconomic data in medical records and cancer registries,49 which 
are common data sources for childhood cancer research. However, it remains important 
to note that SES is a common prior cause of some of these more proximal risk factors 
including birthweight and maternal age. Therefore, these exposures could be considered 
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mediators and although adjusting for them (as we do here in Models 3-4) is a 
conservative approach and typical in the clinical epidemiologic literature, it may 
understate the role of SES in childhood cancer incidence.  
We did identify a statistically significant protective association between higher 
maternal education and hepatoblastoma incidence that was independent of established 
risk factors. Though little is known about the etiology of hepatoblastoma, some studies 
have identified parental tobacco use as a potential risk factor,132 which may contribute to 
a social patterning of incidence. Due to insufficient smoking data in our study, we look to 
future studies to explore this potential mechanism. We note that a similarly designed 
study using pooled data from five US state registries found no evidence of a protective 
association between higher maternal education and risk of hepatic tumors.43 Therefore, 
additional research is needed to replicate our finding and to explore potential effect 
modifiers that may explain cross-place differences. 
Limitations 
This study has several limitations. First, besides education, we could not account 
for other dimensions of individual-level SES, such as household income or occupation. 
Nevertheless, given the lack of individual-level socioeconomic data in cancer registries,49 
our use of maternal education data from birth records improves upon many population-
based cancer studies. Second, because our measures of SES were limited to a single 
exposure window at birth, although a common approach for operationalizing childhood 
SES, we cannot draw conclusions about SES later in childhood. Yet neighborhood SES at 
birth was strongly correlated with SES at diagnosis among cases (Pearson ρ = 0.70), 
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suggesting temporal stability, which has been reported previously.112,133 Third, like many 
prior studies, we were limited by sample size due to the rarity of childhood cancers. This 
prevented us from testing more homogenized cancer subgroups or stratifying by age. It is 
notable however that some SES associations were strong enough to be detected with only 
a case sample of 50 (i.e. hepatoblastoma). Fourth, there is the potential for disease 
misclassification bias if children born in Minnesota subsequently moved out of state and 
developed cancer. However, given the rarity of childhood cancers and low out-migration 
rate among Minnesota youth,134 this is not a major threat to validity. There is also the 
potential for selection bias if cases without a matching birth record were in fact born in 
Minnesota, and thus part of the source cohort. This may have occurred because of 
inconsistent (e.g. name changes) or missing data. We found that unmatched cases resided 
in lower SES neighborhoods at time of diagnosis than matched cases (p <.001), which 
may reflect differences in data quality by SES.125 However, it may also reflect higher 
residential mobility among lower SES cases,112 and thus a higher in-migration rate to 
Minnesota during childhood. Our 86% record linkage rate is comparable to prior registry-
based studies of childhood cancer.135-137 Finally, given the high proportion of non-
Hispanic whites in our sample (82%), results may be less generalizable to more racially 
diverse populations. Despite these limitations, this study provides important insight into 
unpacking the association between SES and childhood cancer incidence.  
Conclusion 
Results from this study suggest that SES has a limited impact on childhood cancer 
incidence, beyond the social patterning of established demographic and pregnancy-
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related risk factors including race/ethnicity, maternal age, and birthweight. It is reassuring 
that these socially patterned risk factors of childhood cancer incidence are already known 
and well described in the literature.  However, given that these exposures only account 
for a small portion of the total disease burden,3 more work is needed to better understand 
childhood cancer etiology. Unfortunately, while it is important to continue monitoring 
socioeconomic differences in risk to ensure health equity, our findings suggest that 
continued investigation of SES associations may generate limited new etiologic insight 
into childhood cancer incidence, at least for the more common cancers. 
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Figure 3-1 Crude associations between categorical SES and combined childhood 
cancer incidence; registry-based case-cohort study, linked Minnesota birth and 
cancer records, 1989-2014 (N=14,854) 
  A. Individual-level SES                 B. Neighborhood-level SES 
    
Notes: Odds ratios estimated from bivariate logistic mixed models of categorical SES (maternal 
education/neighborhood deprivation) predicting combined childhood cancer incidence (all diagnoses). Reference = 
lowest SES category (<high school (HS)/Q1 neighborhood). Standardized census tract SES principal component scores 
categorized into quintiles; Q1 = low SES (high deprivation), Q5 = high SES (low deprivation). 
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Table 3-1 Characteristics of cases and controls; registry-based case-cohort study, 
linked Minnesota birth and cancer records, 1989-2014 (N=14,854) 
    Controls   Cases       % 
Missing Variable   (N=11,907)   (N=2,947)   P   
Birth Characteristics 
        Birth Year, mean (SD)  1999 (6.5)  1999 (6.5)  .87  0.0 
Female, No. (%)  5,861 (49.2)  1,306 (44.3)  <.001  0.0 
Birthweight, mean (SD), g  3,403 (585)  3,437 (608)  .005  0.1 
Gestational Age, mean (SD), wks  38.9 (2.0)  38.8 (2.2)  .014  2.2 
First Born, No. (%)  4,587 (38.7)  1,169 (39.8)  .27  0.5 
Maternal Characteristics 
        Age at Delivery, mean (SD), y  28.1 (5.8)  28.5 (5.7)  .002  0.5 
Non-Hispanic White, No. (%)  9,631 (81.4)  2,496 (85.0)  <.001  0.6 
Education, No. (%)      .002  2.4 
     < high school diploma  1,265 (10.9)  259 (9.0)     
     high school diploma  3,439 (29.6)  808 (28.0)     
     some college  3,106 (26.8)  806 (27.9)     
     ≥ bachelor's degree  3,799 (32.7)  1,013 (35.1)     
Neighborhood SES, mean (SD) -0.02 (1.02)  0.06 (0.92)  <.001  0.0 
Notes: P-values compare characteristics of cases versus controls estimated from Pearson's chi-square test for 
categorical measures and the two-sample t-test for continuous measures. SD = standard deviation; g = grams; 
wks = weeks; y = years; SES = socioeconomic status (higher values = higher SES). 
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Table 3-2 Correlation matrix; registry-based case-cohort study, linked Minnesota 
birth and cancer records, 1989-2014 (N=14,854) 
Variable 1 2 3 4 5 6 7 8 9 
1. Birth Year 1         
2. Female -0.02 1        
3. Mother NH White -0.16 0.01 1       
4. Maternal Age 0.05 0.01 0.18 1      
5. Birthweight -0.04 -0.09 0.11 0.08 1     
6. Gestational Age -0.08 0.03 0.02 -0.03 0.63 1    
7. First Born 0.01 0.02 0.03 -0.32 -0.09 0.02 1   
8. Maternal Education 0.10 0.00 0.28 0.45 0.10 -0.02 0.02 1  
9. Neighborhood SES -0.01 0.00 0.41 0.26 0.09 0.00 0.00 0.35 1 
Notes: Pearson correlation estimated continuous/continuous associations; Spearman correlation estimated 
ordinal/continuous and ordinal/dichotomous associations; tetrachoric correlation estimated dichotomous/dichotomous 
associations; and biserial correlation estimated dichotomous/continuous associations. NH = non-Hispanic; SES = 
socioeconomic status (higher values = higher SES). 
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Table 3-3 Associations between maternal education and childhood cancer incidence; registry-based case-cohort study, linked 
Minnesota birth and cancer records, 1989-2014 (N=14,854) 
  All Childhood Cancers Combined  
Acute Lymphoblastic 
Leukemia  
Acute Myeloid         
Leukemia  Lymphomas  
Central Nervous          
System Tumors 
 
N = 2,947 
 
N = 673 
 
N = 112 
 
N = 311 
 
N = 662 
 OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P 
Model 1A 1.08 (1.04, 1.13) <.001  1.10 (1.02, 1.19) .018  1.03 (0.86, 1.25) .73  1.11 (0.99, 1.25) .066  1.12 (1.04, 1.21) .005 
Model 2A 1.06 (1.01, 1.10) .014  1.08 (1.00, 1.18) .053  1.06 (0.87, 1.29) .55  1.11 (0.98, 1.25) .096  1.06 (0.97, 1.15) .18 
Model 3A 1.03 (0.98, 1.08) .26  1.05 (0.96, 1.16) .27  0.96 (0.78, 1.20) .75  1.12 (0.98, 1.28) .099  1.05 (0.96, 1.16) .29 
Model 4A 1.02 (0.97, 1.07) .36   1.05 (0.95, 1.15) .36   0.95 (0.76, 1.19) .66   1.10 (0.96, 1.26) .18   1.04 (0.95, 1.15) .42 
 
Neuroblastoma 
 
Retinoblastoma 
 
Wilms' Tumor 
 
Hepatoblastoma 
 
Rhabdomyosarcoma 
 
N = 267 
 
N = 80 
 
N = 210 
 
N = 50 
 
N = 79 
 OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P 
Model 1A 1.15 (1.02, 1.30) .028  1.15 (0.91, 1.44) .23  1.15 (1.00, 1.32) .057  0.72 (0.54, 0.94) .017  0.91 (0.73, 1.14) .41 
Model 2A 1.13 (0.99, 1.29) .064  1.21 (0.96, 1.53) .11  1.08 (0.93, 1.25) .32  0.74 (0.55, 0.98) .038  0.85 (0.67, 1.08) .19 
Model 3A 1.07 (0.93, 1.24) .34  1.27 (0.97, 1.68) .088  1.02 (0.86, 1.20) .85  0.69 (0.50, 0.96) .028  0.78 (0.60, 1.01) .061 
Model 4A 1.09 (0.94, 1.26) .28   1.25 (0.94, 1.65) .12   1.02 (0.86, 1.21) .83   0.70 (0.51, 0.98) .037   0.77 (0.59, 1.00) .054 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from logistic mixed models with a random intercept for clustering within census tracts. Model 1A: bivariate 
(crude). Model 2A: adjusted for maternal race/ethnicity. Model 3A: further adjusted for birth year, sex, maternal age, birthweight, gestational age, and birth order. Model 4A: 
further adjusted for neighborhood SES. Maternal education modeled as an ordinal variable; values range from 1 = <12 years, no high school diploma to 4 = 16+ years, advanced 
degree.  Random intercepts dropped from Models 1A-3A for AML and Wilms' tumor due to non-convergence stemming from zero-value intraclass correlations. Control sample: 
N=11,907.  
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Table 3-4 Associations between maternal education and childhood cancer incidence estimated from bivariate and trivariate 
models; registry-based case-cohort study, linked Minnesota birth and cancer records, 1989-2014 (N=14,854) 
  All Cancers Combined   Acute Lymphoblastic Leukemia   Lymphomas 
 
N = 2,947 
 
N = 673 
 
N = 311 
Model OR 95% CI P %Change  OR 95% CI P %Change  OR 95% CI P %Change 
Bivariate 1.08 (1.04, 1.13) <.001   1.10 (1.02, 1.19) .018   1.11 (0.99, 1.25) .066  Trivariate adjusted for:                 Race/Ethnicity 1.06 (1.01, 1.10) .014 30%  1.08 (1.00, 1.18) .053 15%  1.11 (0.98, 1.25) .096 6% 
   Maternal Age 1.06 (1.02, 1.11) .008 20%  1.08 (0.99, 1.18) .082 18%  1.09 (0.96, 1.24) .19 20% 
   Birthweight 1.07 (1.03, 1.12) .001 6%  1.09 (1.00, 1.18) .039 12%  1.11 (0.99, 1.24) .082 5% 
   Gestational Age 1.08 (1.04, 1.13) <.001 -1%  1.10 (1.02, 1.19) .017 0%  1.11 (0.99, 1.25) .067 1% 
   First Born 1.08 (1.04, 1.13) <.001 0%  1.10 (1.02, 1.19) .018 0%  1.11 (0.99, 1.25) .063 -1% 
   Sex 1.08 (1.04, 1.13) <.001 -1%  1.10 (1.02, 1.19) .017 -1%  1.11 (0.99, 1.25) .063 -1% 
   Birth Year 1.08 (1.04, 1.13) <.001 -1%   1.10 (1.02, 1.19) .017 -1%   1.13 (1.01, 1.27) .039 -13% 
 
Central Nervous System Tumors 
 
Neuroblastoma 
 
Wilms' Tumor 
 
N = 662 
 
N = 267 
 
N = 210 
Model OR 95% CI P %Change  OR 95% CI P %Change  OR 95% CI P %Change 
Bivariate 1.12 (1.04, 1.21) .005   1.15 (1.02, 1.30) .028   1.15 (1.00, 1.32) .057  Trivariate adjusted for:                 Race/Ethnicity 1.06 (0.97, 1.15) .18 50%  1.13 (0.99, 1.29) .064 12%  1.08 (0.93, 1.25) .32 46% 
   Maternal Age 1.13 (1.03, 1.23) .008 -5%  1.15 (1.00, 1.32) .046 -2%  1.14 (0.97, 1.33) .12 8% 
   Birthweight 1.11 (1.03, 1.20) .010 8%  1.15 (1.02, 1.30) .026 -2%  1.13 (0.98, 1.30) .099 13% 
   Gestational Age 1.12 (1.03, 1.21) .005 0%  1.15 (1.02, 1.30) .026 -2%  1.15 (1.00, 1.33) .055 -1% 
   First Born 1.12 (1.03, 1.21) .005 1%  1.15 (1.01, 1.30) .029 1%  1.15 (0.99, 1.32) .059 1% 
   Sex 1.12 (1.04, 1.21) .005 0%  1.15 (1.02, 1.30) .026 -1%  1.15 (1.00, 1.32) .057 0% 
   Birth Year 1.13 (1.04, 1.22) .004 -4%   1.12 (0.99, 1.27) .075 19%   1.13 (0.98, 1.31) .083 9% 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from logistic mixed models with a random intercept for census tract clustering. Bivariate models equate to 
Model 1A in Table 3-3. Trivariate models adjusted for maternal race/ethnicity equate to Model 2A in Table 3-3. Random intercepts dropped from Wilms' tumor models due to 
non-convergence stemming from zero-value intraclass correlations. % change compares beta coefficients of maternal education predicting cancer incidence estimated from 
bivariate and trivariate models (i.e. βbivar-βtrivar/βbivar). Control sample: N=11,907.  
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Table 3-5 Associations between neighborhood SES and childhood cancer incidence; registry-based case-cohort study, linked 
Minnesota birth and cancer records, 1989-2014 (N=14,854) 
  All Childhood Cancers Combined   
Acute Lymphoblastic 
Leukemia   
Acute Myeloid         
Leukemia   Lymphomas   
Central Nervous          
System Tumors 
 
N = 2,947 
 
N = 673 
 
N = 112 
 
N = 311 
 
N = 662 
  OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P   OR 95% CI P 
Model 1B 1.09 (1.04, 1.14) <.001  1.10 (1.01, 1.20) .026  1.07 (0.88, 1.30) .52  1.14 (1.01, 1.30) .037  1.18 (1.08, 1.29) <.001 
Model 2B 1.05 (1.00, 1.11) .035  1.08 (0.99, 1.19) .095  1.12 (0.91, 1.39) .30  1.15 (1.00, 1.31) .052  1.09 (0.99, 1.20) .091 
Model 3B 1.04 (0.99, 1.09) .16  1.06 (0.97, 1.17) .22  1.07 (0.86, 1.33) .54  1.15 (1.00, 1.32) .058  1.09 (0.98, 1.20) .11 
Model 4B 1.03 (0.98, 1.09) .21   1.05 (0.96, 1.16) .29   1.08 (0.87, 1.34) .49   1.13 (0.98, 1.30) .10   1.08 (0.97, 1.19) .15 
 
Neuroblastoma 
 
Retinoblastoma 
 
Wilms' Tumor 
 
Hepatoblastoma 
 
Rhabdomyosarcoma 
 
N = 267 
 
N = 80 
 
N = 210 
 
N = 50 
 
N = 79 
 
OR 95% CI P 
 
OR 95% CI P 
 
OR 95% CI P 
 
OR 95% CI P 
 
OR 95% CI P 
Model 1B 1.01 (0.89, 1.15) .82  1.07 (0.85, 1.36) .55  1.13 (0.96, 1.32) .14  0.83 (0.66, 1.03) .089  1.14 (0.87, 1.50) .34 
Model 2B 0.97 (0.84, 1.11) .67  1.16 (0.90, 1.50) .25  1.01 (0.85, 1.20) .90  0.86 (0.67, 1.11) .24  1.06 (0.79, 1.42) .71 
Model 3B 0.95 (0.82, 1.09) .43  1.16 (0.90, 1.51) .25  0.98 (0.83, 1.17) .85  0.88 (0.68, 1.14) .33  1.03 (0.76, 1.40) .83 
Model 4B 0.93 (0.81, 1.08) .35   1.13 (0.87, 1.46) .37   0.98 (0.82, 1.17) .83   0.92 (0.70, 1.20) .52   1.08 (0.79, 1.48) .63 
Notes: Odds ratios (OR) and 95% confidence intervals (CI)  estimated from logistic mixed models with a random intercept for clustering within census tracts. Model 1B: bivariate 
(crude). Model 2B: adjusted for maternal race/ethnicity. Model 3B: further adjusted for birth year, sex, maternal age, birthweight, gestational age, and birth order. Model 4B: 
further adjusted for maternal education. Neighborhood SES modeled as a continuous variable (higher values = higher SES); values range from -7.3 to 1.5 (SD=1).  Control sample: 
N=11,907. 
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Table 3-6 Associations between neighborhood SES and childhood cancer incidence 
estimated from bivariate and trivariate models; registry-based case-cohort study, 
linked Minnesota birth and cancer records, 1989-2014 (N=14,854) 
  All Cancers Combined   Acute Lymphoblastic Leukemia 
 
N = 2,947 
 
N = 673 
Model OR 95% CI P %Change   OR 95% CI P %Change 
Bivariate 1.09 (1.04, 1.14) <.001 
  
1.10 (1.01, 1.20) .026 
 Trivariate adjusted for: 
           Race/Ethnicity 1.05 (1.00, 1.11) .035 39%  1.08 (0.99, 1.19) .095 18% 
   Maternal Age 1.08 (1.03, 1.13) .002 14%  1.09 (0.99, 1.18) .066 15% 
   Birthweight 1.08 (1.04, 1.13) <.001 5%  1.09 (1.00, 1.19) .045 10% 
   Gestational Age 1.09 (1.04, 1.14) <.001 0%  1.10 (1.01, 1.20) .026 0% 
   First Born 1.09 (1.04, 1.14) <.001 0%  1.10 (1.01, 1.20) .026 0% 
   Sex 1.09 (1.04, 1.14) <.001 -1%  1.10 (1.01, 1.20) .026 0% 
   Birth Year 1.09 (1.04, 1.14) <.001 0%  1.10 (1.01, 1.20) .026 0% 
 
Lymphomas 
 
Central Nervous System Tumors 
 
N = 311 
 
N = 662 
Model OR 95% CI P %Change   OR 95% CI P %Change 
Bivariate 1.14 (1.01, 1.30) .037 
  
1.18 (1.08, 1.29) <.001 
 Trivariate adjusted for: 
           Race/Ethnicity 1.15 (1.00, 1.31) .052 0%  1.09 (0.99, 1.20) .091 49% 
   Maternal Age 1.13 (0.99, 1.28) .073 12%  1.18 (1.08, 1.30) .001 0% 
   Birthweight 1.14 (1.00, 1.29) .044 3%  1.17 (1.07, 1.28) .001 4% 
   Gestational Age 1.15 (1.01, 1.30) .037 0%  1.18 (1.08, 1.29) <.001 0% 
   First Born 1.15 (1.01, 1.30) .036 0%  1.18 (1.08, 1.29) <.001 0% 
   Sex 1.15 (1.01, 1.30) .035 -1%  1.18 (1.08, 1.29) <.001 0% 
   Birth Year 1.15 (1.01, 1.30) .036 -1%  1.18 (1.08, 1.29) <.001 0% 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from logistic mixed models with a random 
intercept for clustering within census tracts. Bivariate models equate to Model 1B in Table 3-5. Trivariate models 
adjusted for maternal race/ethnicity equate to Model 2B in Table 3-5. % change compares beta coefficients of 
neighborhood SES predicting cancer incidence estimated from bivariate and trivariate models (i.e. βbivar-
βtrivar/βbivar). Control sample: N=11,907.  
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Table 3-7 Associations between established risk factors and combined childhood 
cancer incidence, unadjusted and adjusted for SES; registry-based case-cohort 
study, linked Minnesota birth and cancer records, 1989-2014 (N=14,854) 
  Model 5                          
(unadjusted for SES) 
  Model 4                             
(adjusted for SES) 
Predictor OR 95% CI P   OR 95% CI P 
Race/Ethnicity 
(NH white vs. otherwise) 
1.23 (1.09, 1.38) .001  1.17 (1.03, 1.33) .015 
Maternal Age 
(per 5-year increase) 
1.05 (1.01, 1.09) .012  1.04 (0.99, 1.08) .111 
Birthweight 
(per 500-gram increase) 
1.11 (1.06, 1.16) <.001  1.10 (1.06, 1.16) <.001 
Gestational Age  
(per 1-week increase) 
0.94 (0.92, 0.97) <.001  0.94 (0.92, 0.97) <.001 
First Born  
(first born vs. otherwise) 
1.11 (1.02, 1.22) .017  1.10 (1.01, 1.21) .036 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from logistic mixed models with a random 
intercept for clustering within census tracts. Model 5: adjusted for maternal race/ethnicity, birth year, sex, maternal 
age, birthweight, gestational age, and birth order. Model 4: further adjusted for maternal education and 
neighborhood SES. NH = non-Hispanic; SES = socioeconomic status. Case sample: N=2,947; Control sample: 
N=11,907. 
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Table 3-8 Associations between established risk factors and childhood cancer incidence, unadjusted and adjusted for SES, by 
cancer type; registry-based case-cohort study, linked Minnesota birth and cancer records, 1989-2014 
  Acute Lymphoblastic Leukemia (N=673)   Acute Myeloid Leukemia (N=112)   Lymphomas (N=311) 
 Model 5 Model 4  Model 5 Model 4  Model 5 Model 4 
 (unadjusted for SES) (adjusted for SES)  (unadjusted for SES) (adjusted for SES)  (unadjusted for SES) (adjusted for SES) Predictor OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P 
Race/Ethnicity 1.11 (0.89, 1.39) .34 1.03 (0.81, 1.32) .79  0.73 (0.46, 1.17) .20 0.70 (0.42, 1.18) .19  1.06 (0.77, 1.45) .73 0.89 (0.64, 1.26) .52 
Maternal Age 1.05 (0.98, 1.13) .17 1.02 (0.94, 1.11) .56  1.16 (0.98, 1.38) .093 1.16 (0.96, 1.41) .12  1.08 (0.97, 1.20) .17 1.02 (0.90, 1.15) .79 
Birthweight 1.20 (1.10, 1.30) <.001 1.19 (1.09, 1.30) <.001  1.23 (1.00, 1.52) .048 1.23 (1.00, 1.52) .048  0.97 (0.85, 1.10) .61 0.96 (0.84, 1.09) .50 Gestational Age 0.92 (0.88, 0.97) <.001 0.92 (0.88, 0.97) .002  0.99 (0.87, 1.13) .88 0.99 (0.87, 1.13) .90  1.04 (0.97, 1.13) .27 1.05 (0.97, 1.13) .23 First Born 1.08 (0.91, 1.28) .37 1.06 (0.89, 1.26) .53   1.00 (0.66, 1.51) .99 1.00 (0.66, 1.53) .99   0.92 (0.72, 1.19) .54 0.88 (0.68, 1.14) .33 
 Central Nervous System Tumors (N=662)  Neuroblastoma (N=267)  Retinoblastoma (N=80) 
 Model 5 Model 4  Model 5 Model 4  Model 5 Model 4 Predictor OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P 
Race/Ethnicity 1.83 (1.41, 2.36) <.001 1.66 (1.26, 2.19) <.001  1.38 (0.97, 1.96) .077 1.40 (0.95, 2.06) .090  0.82 (0.48, 1.42) .49 0.66 (0.37, 1.19) .17 Maternal Age 1.03 (0.95, 1.10) .49 1.00 (0.92, 1.08) .94  1.04 (0.93, 1.17) .49 1.02 (0.89, 1.16) .77  0.93 (0.75, 1.14) .48 0.82 (0.64, 1.06) .13 
Birthweight 1.07 (0.98, 1.17) .12 1.07 (0.98, 1.17) .15  1.06 (0.92, 1.22) .40 1.06 (0.92, 1.21) .43  1.06 (0.83, 1.37) .63 1.05 (0.81, 1.35) .72 
Gestational Age 1.00 (0.95, 1.05) .94 1.00 (0.95, 1.05) .99  0.94 (0.87, 1.01) .092 0.94 (0.87, 1.01) .094  1.01 (0.87, 1.17) .92 1.01 (0.87, 1.18) .88 
First Born 1.18 (0.99, 1.39) .062 1.15 (0.97, 1.37) .11  1.19 (0.91, 1.55) .20 1.17 (0.89, 1.53) .26  1.06 (0.66, 1.71) .81 0.96 (0.59, 1.57) .87 
  Wilms' Tumor (N=210)   Hepatoblastoma (N=50)   Rhabdomyosarcoma (N=79) 
 Model 5 Model 4  Model 5 Model 4  Model 5 Model 4 Predictor OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P   OR 95% CI P OR 95% CI P 
Race/Ethnicity 2.04 (1.25, 3.31) .004 2.05 (1.22, 3.46) .007  0.76 (0.39, 1.48) .42 1.05 (0.49, 2.24) .91  1.41 (0.68, 2.94) .36 1.54 (0.70, 3.38) .28 Maternal Age 1.03 (0.90, 1.18) .63 1.03 (0.89, 1.20) .71  1.04 (0.81, 1.35) .73 1.21 (0.92, 1.59) .17  1.13 (0.91, 1.39) .26 1.23 (0.98, 1.54) .078 Birthweight 1.31 (1.12, 1.53) .001 1.31 (1.12, 1.53) .001  0.82 (0.59, 1.13) .23 0.84 (0.61, 1.16) .30  1.26 (0.98, 1.62) .075 1.28 (0.99, 1.65) .058 
Gestational Age 0.88 (0.81, 0.96) .005 0.88 (0.81, 0.96) .005  0.85 (0.75, 0.97) .017 0.85 (0.75, 0.97) .014  0.87 (0.76, 0.99) .039 0.86 (0.76, 0.99) .036 
First Born 1.18 (0.87, 1.61) .28 1.18 (0.86, 1.61) .30   1.12 (0.61, 2.06) .70 1.26 (0.68, 2.35) .46   1.40 (0.86, 2.29) .17 1.52 (0.93, 2.50) .098 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from logistic mixed models with a random intercept for clustering within census tracts. Model 5: adjusted 
for maternal race/ethnicity, birth year, sex, maternal age, birthweight, gestational age, and birth order. Model 4: further adjusted for maternal education and neighborhood SES. 
Race/ethnicity ORs compare non-Hispanic white mother versus otherwise; maternal age ORs compare 5-year increase; birthweight ORs compare 500-gram increase; gestational 
age ORs compare 1-week increase; and first born ORs compare first live birth versus otherwise. Control sample: N=11,907. 
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Manuscript 3: Does socioeconomic status explain black-white 
racial disparities in childhood cancer survival? 
Introduction 
Despite improvements over the last four decades in cancer survival among the US 
pediatric population, marked racial disparities persist.4,67 Compared to non-Hispanic 
white (white) children, non-Hispanic black (black) children experience lower survival 
from combined (all diagnoses)67 and many individual cancers including leukemias,79-81 
lymphomas,82-84 CNS tumors,85 and extracranial solid tumors.86-88,108 The underlying 
mechanisms accounting for these differences are not well understood, and may vary by 
cancer. As outlined in Figure 4-1, both biological and socioeconomic pathways have been 
proposed in the literature.89,90,106 It is suggested that underlying genetic variations 
associated with ancestry may lead to differences in tumor biology and pharmacogenetics 
for some childhood cancers.90 For example, compared to whites, black patients with 
neuroblastoma are more likely to have characteristics of high-risk disease, including older 
age at presentation and unfavorable tumor histology.86 A higher proportion of 
unfavorable tumor characteristics among black compared to white patients has also been 
documented for acute lymphoblastic leukemia (ALL),92-94 Hodgkin lymphoma (HL),95 
rhabdomyosarcoma,96 and central nervous system (CNS) tumors.85 However, race is a 
socially constructed taxonomy that is not synonymous with ancestry.91 Race is highly 
correlated with socioeconomic status (SES),103,104 especially in the United States where 
embedded institutionalized racism continues to place racial and ethnic minorities at high 
risk of low SES.105 Evidence is emerging of a positive association between higher SES 
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and childhood cancer survival.85,87,106-108 Therefore, SES may also contribute to racial 
survival differences through mechanisms such as treatment adherence and access to 
quality health care, including enrollment into clinical trials.90  
Disentangling the relative role of social versus biological pathways in explaining 
survival differences by race is important for practice and intervention implications. If 
underlying socioeconomic factors explain survival differences by race (e.g. worse 
healthcare coverage among blacks compared to whites results in inferior treatment), then 
interventions addressing social and economic barriers to care are warranted to address 
racial disparities. On the other hand, if SES does not account for survival differences by 
race, then biological mechanisms, such as tumor biology and pharmacogenetics, must be 
considered. In this case, investment in developing novel and personalized drug therapies 
may be appropriate. Moreover, if both social and biological factors contribute to survival 
differences, then a multipronged intervention approach may ultimately be needed.  
Formal mediation methods are required to empirically test the underlying 
pathways (i.e. mediators) contributing to survival differences by race. Through mediation 
analysis, the proportion of the race-survival association explained by a given pathway 
(e.g. SES) can be estimated to ultimately provide insight into which factors should be 
targeted in interventions addressing survival disparities. However, to date, mediation 
methods have not been used in the childhood cancer literature. In this study, we 
conducted a formal mediation analysis to determine whether SES mediates the 
association of race (black versus white) and childhood cancer survival and, if so, to what 
degree. We also tested prognostic factors, including tumor stage and treatment, as other 
potential mediators. We used population-based data representative of the US pediatric 
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cancer population, and we assessed survival from combined and individual childhood 
cancers to determine if mediation differs across tumor groups.  
Methods 
Study Population 
We obtained population-based data from the Surveillance, Epidemiology, and 
End Results (SEER) 18 database, excluding the Alaska Native Tumor Registry.138 We 
restricted to black and white cases, ages 0 to 19 years, with microscopically confirmed 
first primary malignancies. The main predictor of interest was race/ethnicity, based on 
provider’s report in the medical record.139 We restricted to black and white cases because 
of the magnitude of the disparity and small case counts among other racial and ethnic 
groups.140 SES data were available in SEER for years 2000 to 2012. Therefore, we 
further restricted to cases diagnosed January 1, 2000 to December 31, 2011, followed 
through December 31, 2012. This allowed for at least one year of follow-up. We 
excluded 37 cases staged with in situ tumors, 428 cases with missing or zero months of 
follow-up time, and 568 cases with missing SES data. Our final analytic sample consisted 
of 27,741 cases (4,529 blacks; 23,212 whites). We assessed overall survival from 
combined and individual cancers (where N ≥ 200 cases per group) based on the 
International Classification of Childhood Cancer, third edition.113  Overall survival was 
pre-calculated in SEER as months from date of diagnosis to date of death from any cause, 
or censored at date of last contact.  
Potential Mediators 
Socioeconomic Status – We measured SES, at date of cancer diagnosis, using the 
validated census tract-level composite index available in the restricted SEER database.141 
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As described previously,142 the index was constructed using factor analysis of 2000 
decennial census data and 2005-2009 American Community Survey (ACS) data.141 Seven 
measures of SES, specified by Yost et al. (2001), were included in the index: proportion 
employed in working-class occupations, proportion aged 16+ unemployed, education 
index,143 median household income, proportion below 200% poverty level, median rent, 
and median house value.144 Addresses at diagnosis were geocoded to census tracts, 2000 
geographic boundaries. 2000 census values were assigned to cases diagnosed 2000-2003; 
2005-2009 ACS values were assigned to cases diagnosed 2004-2011.141 The index is 
available in SEER as a five-level variable categorized into quintiles (Q1, low SES; Q5, 
high SES). In a secondary analysis, we tested individual-level health insurance status as 
an alternative measure of SES defined as (1) private, (2) any Medicaid, (3) insured, no 
specifics, (4) uninsured, and (5) unknown.  
Treatment and Stage – First-course cancer-directed surgery (surgery) was defined 
as (1) surgery performed versus (0) otherwise. Radiation therapy (radiation) was defined 
as (1) beam radiation, combination of beam radiation with implant or isotopes, radiation 
not otherwise specified, radioactive implants, or radioisotopes versus (0) otherwise. 
Distal stage at diagnosis (distal stage) was defined as (1) distant site(s)/nodes involved 
versus (0) otherwise, based on SEER summary staging classifications.145 Surgery and 
stage do not apply to leukemias.  
Statistical Analysis 
We compared characteristics of black and white cases using Pearson’s chi-square 
test for categorical measures and the two sample t-test for continuous measures. For each 
cancer type, we estimated black-white mortality hazard ratios (total effects) from 
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multivariable Cox proportional hazards regression adjusted for age group at diagnosis 
(<1, 1-4, 5-9, 10-14, 15-19 years), year of diagnosis (modeled linearly), and sex. For 
cancers with a statistically significant black-white mortality hazard ratio, we used the 
inverse odds weighting (IOW) method to test for mediation.146,147 IOW is a 
semiparametric weight-based approach that overcomes many limitations of traditional 
parametric mediation methods.148 For example, IOW is appropriate for any functional 
form (rather than just linear models), can test multiple mediators simultaneously (as 
opposed to testing them one by one), and is valid even in the presence of exposure-
mediator interactions.149 We tested for mediation by (1) SES, (2) treatment and stage, and 
(3) SES, treatment, and stage. For cancers in which the census tract SES index 
significantly mediated the race-survival association, we further tested for mediation by 
health insurance status. This secondary analysis was restricted to cases diagnosed 2007-
2011 (N=11,225), when health insurance data became available in SEER.  
Implementation of the IOW method has been described in detail previously.149 
Briefly, we estimated the total effect of race on survival by specifying an unweighted 
multivariable Cox proportional hazards model adjusted for age group, sex, and year of 
diagnosis. The total effect provides an estimate of the overall association between race 
and survival, without specifying any mediating pathways (so it captures all possible 
mediators).150 We then estimated the (natural)150 direct effect of race on survival by 
specifying a multivariable Cox proportional hazards model adjusted for age group, sex, 
and year of diagnosis, weighted by the IOW weight. Weight specification renders the 
exposure and mediator(s) independent, thus “blocking” the indirect pathway through the 
tested mediator(s).151 Therefore, the direct effect provides an estimate of the race-survival 
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association that remains after accounting for the pathway through the tested 
mediator(s).150 To create the IOW weights operationally, we first recovered the predicted 
odds of exposure (i.e. black race) for each subject from a multivariable logistic regression 
model specifying mediator(s), age group, sex, and year of diagnosis. We then took the 
inverse of the predicted odds to create the IOW weight for whites; blacks were assigned a 
weight of one. Black race was selected as the reference population to minimize extreme 
weighting values. Finally, we estimated the (natural)150 indirect effect of race on survival 
operating through the tested mediator(s) by subtracting the direct (log hazard ratio (β)) 
from the total effect, and bootstrapping to obtain standard errors (500 replications). A 
significant indirect effect provides statistical evidence that the tested variable(s) does in 
fact mediate the race-survival association. To quantify the mediation magnitude, we 
calculated the percent change between the total and direct effect ((βtotal - βdirect)/βtotal), 
which estimates the proportion of the race-survival association explained by the tested 
mediator(s). Statistical significance was determined as p <.05 for a 2-sided hypothesis 
test. Within each set of IOW results, we adjusted p-values for multiple comparisons using 
the Benjamini-Hochberg method,152 implemented in R 3.1.3.153 All other analyses were 
performed using Stata 14.2 (College Station, TX).114 
Results 
Characteristics of combined childhood cancer cases are provided in Table 4-1. 
Average follow-up time was 70.3 months (standard deviation, 44.1; range, 1-155); 15.9% 
of cases died by end of follow-up. Black cases were younger, more likely to be female, 
and more likely to have distal stage disease at diagnosis compared to whites. Blacks were 
more likely to undergo radiation, while whites were more likely to undergo surgery. SES 
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was significantly lower among blacks compared to whites; 40.1% of blacks were in the 
lowest SES quintile (Q1) compared to 11.2% of whites. Comparisons by individual 
cancer type are provided in Table 4-2. 
Table 4-3 presents hazard ratios comparing all-cause mortality in black and white 
childhood cancer cases, adjusted for age group, sex, and year of diagnosis (total effects). 
Blacks had 71% higher hazard of death compared to whites for combined childhood 
cancers (Mortality HR, 1.71; 95% CI, 1.59, 1.83). Among individual cancers, blacks had 
significantly higher mortality compared to whites for 8 of the 12 cancers, including ALL, 
acute myeloid leukemia (AML), HL, non-Hodgkin lymphoma (NHL), astrocytomas, non-
astrocytoma CNS tumors (other CNS), neuroblastoma, and non-rhabdomyosarcoma soft 
tissue sarcomas (NRSTS). Mortality hazard ratios for race were not statistically 
significant for rhabdomyosarcoma, Wilms’ tumor (WT), osteosarcoma, or germ cell 
tumors (GCT). Survival curves by race are provided in Figure 4-2; similar patterns 
emerged on the absolute scale. 
IOW results for mediation by SES are presented in Table 4-4. We determined 
SES to be a significant mediator of the race-survival association if the percent change 
between the total and direct effect was ≥ 10%, and if the indirect effect of race on 
survival operating through SES was statistically significant. Based on these criteria, SES 
was identified as a significant mediator of the race-survival association for combined 
childhood cancers (indirect effect HR (iHR), 1.12; 95% CI, 1.08, 1.15; p <.001; 20% 
change), ALL (iHR, 1.18; 95% CI, 1.08, 1.29; p <.001; 44%), and AML (iHR, 1.16; 95% 
CI, 1.04, 1.29; p = .017; 28%). The percent change was >10% for HL (11%), NHL 
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(32%), astrocytomas (12%), other CNS (18%), and neuroblastoma (22%), though indirect 
effects were non-significant.  
As shown in Table 4-5, when we substituted individual-level health insurance 
status for tract-level SES, comparable indirect effects were estimated for combined 
childhood cancers (iHR, 1.10; 95% CI, 1.05, 1.15; p <.001; 19% change), ALL (iHR, 
1.19; 95% CI, 0.96, 1.46; p = .14; 37%), and AML (iHR, 1.06; 95% CI, 0.92, 1.22; p = 
.45; 13%), though power was reduced. 
IOW results for treatment and stage are shown in Table 4-6. Treatment and stage 
significantly mediated the race-survival association for astrocytomas (iHR, 1.19; 95% CI, 
1.01, 1.40, p = .044; 27%) and neuroblastoma (iHR, 1.16; 95% CI, 1.04, 1.30; p = .015; 
32%). The percent change was >10% for NRSTS (14%), but the indirect effect was non-
significant (p = .59). No additional statistically significant indirect effects emerged when 
we specified SES, treatment, and stage as simultaneous mediators (Table 4-7). 
Discussion 
This is the first study to use formal mediation methods to unpack childhood 
cancer survival disparities by race. In our analysis, we replicated findings that whites 
have a significant survival advantage over blacks for many childhood cancers including 
leukemias,79-81 lymphomas,82-84 CNS tumors,85 neuroblastoma,86 and NRSTS.88 As with 
prior studies, we found no significant survival differences for rhabdomyosarcoma, WT, 
osteosarcoma, or GCT.67,87 Thus, race does not appear to be uniformly associated with 
survival across all types of childhood cancer.  
For cancers with significant survival differences by race, we used novel methods 
to test the hypothesis of whether SES accounts for the disparity. In IOW analysis, SES 
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(operationalized as an area-based composite index) was found to significantly mediate 
the race-survival association for combined childhood cancers and leukemias, accounting 
for between 20 and 44% of the disparity. We found comparable results when we used a 
secondary measure of SES operationalized at the individual-level, health insurance status. 
Though power was reduced (health insurance data only available 2007-2011), these 
secondary findings reinforce the role of SES in survival from childhood leukemias, 
particularly ALL.   
Prior literature suggests that the strong association between SES and ALL 
survival may be explained by differences in treatment adherence.90 ALL treatment 
requires a prolonged maintenance phase composed of oral administration of 
antimetabolites to prevent relapse.90 Low SES families may confront multiple barriers to 
maintaining therapy, including low health literacy, poor patient-provider communication, 
and economic constraints, such as inadequate health insurance coverage.90 This is 
supported by a 2012 study that found lower treatment adherence among children with 
ALL living in a single-mother household versus a two-parent household.154 Treatment 
differences may also explain the association between SES and AML survival. Studies 
among adult AML patients have reported positive associations between higher SES and 
receipt of chemotherapy and hematopoietic cell transplantation (HCT).155,156 Further, a 
study by Knight et al. found that stress-related gene expression profiles associated with 
SES may directly influence HCT outcomes.157 Additional research exploring 
socioeconomic differences in treatment protocol and adherence are needed in the 
pediatric population to ultimately inform interventions addressing survival disparities.  
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SES was not identified as a significant mediator of the race-survival association 
for childhood solid tumors. However, treatment and stage were found to mediate the 
race-survival association for astrocytomas and neuroblastoma. We tested whether SES 
(modeled ordinally) was associated with treatment and stage, but found no significant 
associations among astrocytoma cases, and found only an association between surgery 
and SES among neuroblastoma cases (Table 4-8). Yet, surgery was not associated with 
race among neuroblastoma cases (Table 4-2). Taken together, these findings provide 
some indirect evidence that non-social factors, such as tumor biology, may contribute to 
survival differences by race for these cancers. Prior studies have reported a greater 
proportion of high-risk disease among black compared to white children diagnosed with 
CNS tumors85 and neuroblastoma.86  
We did not identify any significant mediators for the other types of solid tumors 
with survival differences by race (HL, NHL, other CNS, and NRSTS). For HL, this may 
be due to high overall survival in both racial groups (5-year survival black vs. white: 94% 
vs. 96%), and thus a relatively small disparity on the absolute scale. This may also 
explain why we found no survival differences for WT or GCT, which both have very 
high survival rates (Figure 4-2). For NHL, other CNS, and NRSTS, significant mediating 
effects may have been obscured by tumor heterogeneity (e.g. differences in cellular 
morphology, gene expression, or metastatic potential) within cancer groups. Further 
stratification into relevant subgroups may be required to detect mediators for these 
cancers. For example, because we observed a marginally significant indirect effect of 
SES for NHL cases, further tumor stratification may reveal even stronger SES 
associations for specific subtypes of NHL.  
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Limitations 
There are several limitations to this study. First, SEER’s tract-level SES index 
was only available for years 2000-2012, which restricted sample size and follow-up time. 
This prevented us from testing more homogenized cancer subgroups or stratifying by age. 
Second, because individual-level health insurance data were only available for a subset of 
our sample (diagnosed 2007-2011), we relied on an area-based index as our primary 
measure of SES. Though use of this measure improves upon many prior population-based 
cancer studies, tract-level SES is still a proxy for individual-level SES.158,159 Measures of 
individual-level SES may reveal stronger associations between SES and survival,107 
especially since area-level and individual-level SES may have independent effects on 
health. Given the limitations of our SES measure, we caution readers against interpreting 
weak or null SES findings as evidence of a biological effect, especially since 
nondifferential measurement error can bias effects towards the null.160 Third, we lacked 
geographic variables to explore potential spatial variations in survival. Fourth, the dearth 
of clinical data in SEER limited our ability to account for therapeutic and biological 
factors, such as cytogenetic or molecular features. We also lacked detailed diagnostic and 
staging information specific to childhood cancers,161 which may help inform whether 
entry into care contributes to survival differences. We acknowledge that richer data may 
be available in clinic-based studies, but note that these studies can be hampered by issues 
of internal and external validity.90,116 Fifth, there is the potential for differential loss to 
follow-up by race or SES, though a prior study reported no significant differences in 
follow-up between black and white SEER cases (all ages and cancers, 2000-2008).162 
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Finally, because we only considered disparities between black and white children, 
additional research is needed for other racial and ethnic groups.  
Conclusion 
Through the application of formal mediation methods, we estimated that SES 
accounts for 20% of the racial disparity in survival for combined childhood cancers, and 
nearly half of the disparity for ALL specifically. These findings suggest that childhood 
cancer survival differences by race could theoretically be addressed through initiatives 
that reduce social and economic barriers to effective care. Such efforts may include 
expanded healthcare coverage, improved patient care coordination, increased health 
literacy, provider education, and supplementation of transportation and childcare costs 
during treatment. However, because SES did not fully account for survival disparities in 
our analysis, we cannot rule out other possible explanations (including tumor biology) for 
survival differences by race, especially for astrocytomas and neuroblastoma. Therefore, a 
multipronged intervention approach that addresses socioeconomic barriers to care and 
invests in novel and personalized treatment regimens may ultimately be needed to fully 
eliminate childhood cancer survival differences.  
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Figure 4-1 Conceptual model of mediating pathways between race and childhood 
cancer survival
Race Survival 
Biological Pathway 
 
Tumor Biology  
Pharmacogenomics 
Socioeconomic Pathway 
 
Timely Diagnosis and Entry into Care 
Treatment Adherence 
Access to Quality Health Care 
 73 
 
Table 4-1 Characteristics of combined childhood cancer cases, ages 0-19 years, 
overall and by race, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
 Entire Sample 
(N=27,741) 
Black Cases           
(N=4,529) 
White Cases 
(N=23,212) P Variable 
Follow-Up Months, mean 
(SD) 
70.3 (44.1) 63.9 (43.4) 71.61 (44.1) <.001 
All-Cause Mortality, No. 
(%) 
4,414 (15.9) 1,043 (23.0) 3,371 (14.5) <.001 
Age at Diagnosis, years, 
mean (SD) 
10.0 (6.4) 9.7 (6.3) 10.1 (6.5) <.001 
Age Group at Diagnosis, 
years, No. (%) 
   <.001 
     <1 1,682 (6.1) 298 (6.6) 1,384 (6.0)  
     1-4 6,502 (23.4) 1,048 (23.1) 5,454 (23.5)  
     5-9 4,443 (16.0) 794 (17.5) 3,649 (15.7)  
     10-14 5,534 (20.0) 1,029 (22.7) 4,505 (19.4)  
     15-19 9,580 (34.5) 1,360 (30.0) 8,220 (35.4)  
Female, No. (%) 12,767 (46.0) 2,157 (47.6) 10,610 (45.7) .018 
Radiation Therapy, No. (%) 7,252 (26.1) 1,252 (27.6) 6,000 (25.9) .012 
First-Course Cancer-
Directed Surgery, No. (%) 
16,275 (58.7) 2,581 (57.0) 13,694 (59.0) .012 
Distal Stage at Diagnosis, 
No. (%) 
11,053 (39.8) 1,898 (41.9) 9,155 (39.4) .002 
Neighborhood SES, No. (%)    <.001 
     Q1 (lowest SES) 4,423 (15.9) 1,816 (40.1) 2,607 (11.2)  
     Q2 4,821 (17.4) 1,025 (22.6) 3,796 (16.4)  
     Q3 5,344 (19.3) 799 (17.6) 4,545 (19.6)  
     Q4 5,997 (21.6) 568 (12.5) 5,429 (23.4)  
     Q5 (highest SES) 7,156 (25.8) 321 (7.1) 6,835 (29.5)  
Notes: P-values compare characteristics of black versus white cases estimated from Pearson's chi-square test for 
categorical measures and the two-sample t-test for continuous measures. SD = standard deviation; SES = 
socioeconomic status. 
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Table 4-2 Characteristics of childhood cancer cases by cancer type, ages 0-19 years, 
overall and by race, SEER 18 registries, 2000-2011 diagnoses 
  
Survival 
Months 
All-Cause 
Mortality 
Age at 
Diagnosis  Female           
% 
Radiation    
%  
Surgery    
% 
Distal               
% 
Tract-Level SES Index % 
Cancer N Mean (SD) % Mean (SD) Q1 Q2 Q3 Q4 Q5 
Acute Lymphoblastic Leukemia           Black 634 68.2 (41.9) 15.9 7.5 (5.4) 41.5 14.4 n/a n/a 38.0 23.3 17.4 14.0 7.3 
White 4,357 74.0 (43.1) 10.1 6.6 (5.2) 42.9 10.8 n/a n/a 11.5 16.8 19.2 23.4 29.1 
p-value  .001 <.001 <.001 .50 .008   <.001    Acute Myeloid Leukemia           Black 253 48.5 (43.0) 45.9 8.7 (6.4) 46.6 10.7 n/a n/a 40.7 20.6 16.6 13.4 8.7 
White 965 58.1 (45.1) 30.4 9.3 (6.8) 47.4 11.2 n/a n/a 14.0 16.5 18.8 24.9 25.9 
p-value  .002 <.001 .16 .84 .82   <.001    Hodgkin Lymphoma            Black 384 73.4 (40.1) 7.6 14.4 (3.9) 48.4 50.8 47.4 41.4 41.7 26.3 15.1 10.2 6.8 
White 1,947 79.5 (41.7) 4.9 15.4 (3.4) 48.1 49.8 48.5 31.1 10.9 16.1 19.2 24.2 29.6 
p-value  .009 .033 <.001 .91 .73 .68 <.001 <.001    
Non-Hodgkin Lymphoma           Black 343 63.8 (42.0) 19.2 12.8 (4.7) 41.1 18.1 30.6 44.6 40.5 24.5 17.5 11.1 6.4 
White 1,169 72.5 (45.0) 13.2 12.8 (5.0) 36.4 15.7 34.6 45.0 11.6 15.1 18.8 25.2 29.3 
p-value  .002 .005 .95 .12 .29 .17 .90 <.001    
Astrocytomas            Black 360 62.6 (44.9) 26.4 8.9 (5.5) 49.2 23.9 82.5 1.7 36.7 19.4 20.8 13.9 9.2 
White 2,080 72.0 (45.5) 15.1 9.3 (5.6) 47.0 19.8 86.5 1.8 11.5 17.3 19.2 23.9 28.2 
p-value  <.001 <.001 .17 .44 .076 .045 .83 <.001    
Other CNS Tumors            Black 326 56.4 (45.3) 40.8 7.4 (5.6) 50.6 54.9 87.1 13.8 44.8 20.6 16.0 14.1 4.6 
White 1,718 63.3 (45.4) 29.3 7.9 (5.9) 40.9 57.2 89.8 13.4 11.4 16.0 20.3 23.5 29.0 
p-value  .012 <.001 .11 .001 .45 .16 .84 <.001    
Neuroblastoma            Black 264 56.6 (39.4) 30.7 3.2 (3.8) 50.0 29.9 79.6 57.6 39.4 22.0 20.5 12.5 5.7 
White 1,214 67.1 (43.9) 19.1 2.4 (3.2) 47.5 20.9 79.4 46.8 12.4 17.6 21.1 21.8 27.1 
p-value  <.001 <.001 <.001 .47 .002 .96 .001 <.001    
Non-Rhabdomyosarcoma STS           Black 296 63.9 (45.2) 26.7 12.1 (5.7) 49.3 32.8 84.8 14.2 39.9 21.3 18.6 13.9 6.4 
White 974 69.2 (44.8) 20.1 12.0 (5.9) 45.2 32.6 86.7 13.5 8.1 18.3 20.2 23.3 30.1 
p-value  .077 .016 .88 .21 .94 .42 .75 <.001    
Rhabdomyosarcoma            Black 208 54.8 (41.3) 36.5 8.5 (5.7) 40.9 61.5 61.5 27.9 35.6 26.9 17.3 13.0 7.2 
White 656 62.0 (44.2) 31.6 8.0 (5.8) 41.5 66.9 56.9 29.6 11.3 17.2 17.8 23.8 29.9 
p-value  .040 .18 .25 .88 .15 .23 .64 <.001    
Wilms' Tumor            Black 254 72.0 (44.7) 7.5 3.6 (2.5) 55.1 42.5 96.9 28.7 42.9 22.1 15.0 11.8 8.3 
White 789 72.7 (43.1) 7.4 3.5 (3.3) 51.7 44.1 96.7 22.6 12.8 18.4 19.4 22.8 26.6 
p-value  .82 .95 .67 .34 .66 .91 .045 <.001    
Osteosarcoma            Black 217 63.8 (43.9) 30.4 13.5 (4.0) 43.8 1.8 86.6 20.7 39.6 25.8 16.6 10.6 7.4 
White 619 62.3 (42.0) 33.0 13.3 (3.7) 45.6 3.6 90.3 17.6 8.2 18.4 21.7 24.7 27.0 
p-value  .65 .49 .58 .65 .21 .13 .31 <.001    
Germ Cell Tumors            Black 231 76.7 (43.4) 7.4 12.4 (6.5) 67.5 16.5 89.2 20.8 42.4 21.7 16.0 11.7 8.2 
White 1,549 77.6 (43.1) 5.7 14.0 (6.0) 31.0 13.7 90.1 14.5 10.8 15.7 20.2 24.0 29.4 
p-value   .77 .31 <.001 <.001 .26 .66 .013 <.001       
Notes: P-values compare characteristics among black versus white cases estimated from Pearson's chi-square test for 
categorical measures and the two-sample t-test for continuous measures. Surgery and stage are not applicable (n/a) to 
leukemias. SD = standard deviation; SES = socioeconomic status; CNS = central nervous system; STS = soft tissue sarcomas. 
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Table 4-3 Comparison of all-cause mortality in black versus white cases of combined and individual childhood cancers, ages 0 
to 19 years, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
 Sample Size  Mortality Hazard 
Ratio             
(black vs. white) 
 
Cancer 
Entire 
Sample 
Black 
Cases 
White 
Cases 
 
95% CI P 
Combined Cancers 27,741 4,529 23,212  1.71 (1.59, 1.83) <.001 
Acute Lymphoblastic Leukemia (ALL) 4,991 634 4,357  1.47 (1.18, 1.82) .001 
Acute Myeloid Leukemia (AML) 1,218 253 965  1.69 (1.37, 2.10) <.001 
Hodgkin Lymphoma (HL) 2,331 384 1,947  1.74 (1.15, 2.65) .009 
Non-Hodgkin Lymphoma (NHL) 1,512 343 1,169  1.60 (1.20, 2.14) .001 
Astrocytomas 2,440 360 2,080  1.91 (1.52, 2.41) <.001 
Non-Astrocytoma CNS Tumors (other CNS) 2,044 326 1,718  1.53 (1.26, 1.86) <.001 
Neuroblastoma  1,478 264 1,214  1.59 (1.23, 2.06) <.001 
Non-Rhabdomyosarcoma STS (NRSTS) 1,270 296 974  1.44 (1.11, 1.87) .006 
Rhabdomyosarcoma 864 208 656  1.28 (0.98, 1.67) .070 
Wilms' tumor (WT) 1,043 254 789  1.03 (0.61, 1.74) .90 
Osteosarcoma  836 217 619  0.88 (0.67, 1.17) .39 
Germ Cell Tumors (GCT) 1,780 231 1,549  1.21 (0.71, 2.08) .49 
Notes: Mortality hazard ratios compare all-cause mortality in black versus white cases estimated from multivariable Cox proportional hazards regression models adjusted for 
age category, sex, and year of diagnosis. CNS = central nervous system; STS = soft tissue sarcomas. 
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Figure 4-2 Kaplan-Meier survival curves by race, combined and individual 
childhood cancers, ages 0 to 19 years, SEER 18 registries, 2000-2011 diagnoses 
(N=27,741) 
 a. Combined Cancers            b. ALL                                   c. AML                                                          
 
 d. HL                                     e. NHL                                   f. Astrocytomas
 
 g. Other CNS                         h. Neuroblastoma                  i. NRSTS                                                         
 
 j. Rhabdomyosarcoma           k. WT                                    l. Osteosarcoma
 
 m. GCT                                         
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leukemia; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; 
other CNS = non-astrocytoma central nervous system tumors; NRSTS 
= non-rhabdomyosarcoma soft tissue sarcomas; WT = Wilms’ tumor; 
GCT = germ cell tumors. 
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Table 4-4 Mediating effect of SES on the race-survival association for combined and individual childhood cancers, ages 0 to 19 
years, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
  
Total Effect                                    
of black race on survival                    
through all mediating      
pathways                     
 
Direct Effect                                       
of black race on survival                  
after blocking                                       
SES pathway 
Indirect Effect                              
of black race on survival                 
operating through                                                        
SES pathway 
 
Percent 
Change     
from total to
direct effect 
Cancer Mortality HR 95% CI P   Mortality HR 95% CI P   Mortality HR 95% CI P   % 
Combined 1.71 (1.59, 1.83) <.001  1.53 (1.42, 1.65) <.001  1.12 (1.08, 1.15) <.001  20% 
ALL 1.47 (1.18, 1.82) .002  1.24 (0.98, 1.57) .095  1.18 (1.08, 1.29) <.001  44% 
AML 1.69 (1.38, 2.09) <.001  1.46 (1.16, 1.85) .002  1.16 (1.04, 1.29) .017  28% 
HL 1.74 (1.11, 2.74) .024  1.64 (0.97, 2.78) .087  1.06 (0.81, 1.40) .68  11% 
NHL 1.60 (1.18, 2.17) .005  1.37 (0.98, 1.94) .087  1.16 (0.99, 1.37) .087  32% 
Astrocytomas 1.91 (1.54, 2.38) <.001  1.77 (1.40, 2.25) <.001  1.08 (0.98, 1.19) .14  12% 
Other CNS 1.53 (1.25, 1.87) <.001  1.42 (1.13, 1.79) .006  1.08 (0.96, 1.20) .20  18% 
Neuroblastoma 1.59 (1.24, 2.04) <.001  1.44 (1.09, 1.89) .017  1.11 (0.97, 1.27) .15  22% 
NRSTS 1.44 (1.10, 1.88) .014   1.43 (1.02, 2.00) .059   1.01 (0.84, 1.21) .91   3% 
Notes: Mortality hazard ratios (HR) compare all-cause mortality in black versus white cases. Inverse odds weighting method used to test for mediation. Models adjusted for age 
category, sex, and year of diagnosis. P-values adjusted for multiple comparisons using the Benjamini-Hochberg method. Combined = all cancer diagnoses; ALL = acute 
lymphoblastic leukemia; AML = acute myeloid leukemia; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; other CNS = non-astrocytoma central nervous system 
tumors; NRSTS = non-rhabdomyosarcoma soft tissue sarcomas. 
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Table 4-5 Mediating effect of health insurance status on the race-survival association for combined and childhood leukemias, 
ages 0 to 19 years, SEER 18 registries, 2000-2011 diagnoses (N=11,225) 
  
Total Effect                                    
of black race on survival                    
through all mediating        
pathways                     
 
Direct Effect                                       
of black race on survival                  
after blocking health                                   
insurance pathway 
 
Indirect Effect                              
of black race on survival                 
operating through health                                                        
insurance pathway 
Percent 
Change     
from total to 
direct effect 
Cancer Mortality HR 95% CI P   Mortality HR 95% CI P   Mortality HR 95% CI P   % 
Combined 1.67 (1.47, 1.88) <.001  1.52 (1.33, 1.73) <.001  1.10 (1.05, 1.15) <.001  19% 
ALL 1.59 (1.02, 2.49) .074  1.34 (0.83, 2.18) .26  1.19 (0.96, 1.46) .14  37% 
AML 1.54 (1.03, 2.29) .074   1.45 (0.95, 2.23) .13   1.06 (0.92, 1.22) .45   13% 
Notes: Mortality hazard ratios (HR) compare all-cause mortality in black versus white cases. Inverse odds weighting method used to test for mediation. Models adjusted for age 
category, sex, and year of diagnosis. P-values adjusted for multiple comparisons using the Benjamini-Hochberg method. Combined = all cancer diagnoses; ALL = acute 
lymphoblastic leukemia; AML = acute myeloid leukemia. 
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Table 4-6 Mediating effect of treatment and stage on the race-survival association for combined and individual childhood 
cancers, ages 0 to 19 years, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
  
Total Effect                                    
of black race on survival                    
through all mediating          
pathways                     
 
Direct Effect                                       
of black race on survival                  
after blocking treatment            
and stage pathway 
Indirect Effect                              
of black race on survival                 
operating through treatment                        
and stage pathway 
 
Percent 
Change     
from total to 
direct effect 
Cancer Mortality HR 95% CI P   Mortality HR 95% CI P   Mortality HR 95% CI P   % 
Combined 1.71 (1.59, 1.83) <.001  1.65 (1.54, 1.77) <.001  1.03 (1.02, 1.05) <.001  6% 
ALL 1.47 (1.18, 1.82) .002  1.44 (1.15, 1.79) .002  1.02 (0.99, 1.05) .20  5% 
AML 1.69 (1.38, 2.09) <.001  1.72 (1.39, 2.13) <.001  0.98 (0.95, 1.02) .45  -3% 
HL 1.74 (1.11, 2.74) .021  1.67 (1.06, 2.63) .038  1.05 (0.97, 1.13) .28  8% 
NHL 1.60 (1.18, 2.17) .004  1.61 (1.18, 2.19) .006  1.00 (0.93, 1.07) .92  -1% 
Astrocytomas 1.91 (1.54, 2.38) <.001  1.61 (1.34, 1.93) <.001  1.19 (1.01, 1.40) .044  27% 
Other CNS 1.53 (1.25, 1.87) <.001  1.51 (1.23, 1.86) <.001  1.01 (0.96, 1.07) .69  3% 
Neuroblastoma 1.59 (1.24, 2.04) <.001  1.37 (1.09, 1.74) .014  1.16 (1.04, 1.30) .015  32% 
NRSTS 1.44 (1.10, 1.88) .013   1.37 (1.08, 1.74) .015   1.05 (0.89, 1.24) .59   14% 
Notes: Mortality hazard ratios (HR) compare all-cause mortality in black versus white cases. Inverse odds weighting method used to test for mediation. Models adjusted for age 
category, sex, and year of diagnosis. Surgery and stage do not apply to leukemias. P-values adjusted for multiple comparisons using the Benjamini-Hochberg method. Combined 
= all cancer diagnoses; ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; other CNS = non-
astrocytoma central nervous system tumors; NRSTS = non-rhabdomyosarcoma soft tissue sarcomas. 
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Table 4-7 Mediating effect of SES, treatment, and stage on the race-survival association for combined and individual 
childhood cancers, ages 0 to 19 years, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
  
Total Effect                                    
of black race on survival                    
through all mediating          
pathways                     
 
Direct Effect                                       
of black race on survival                  
after blocking SES, treatment,        
and stage pathways 
Indirect Effect                              
of black race on survival                 
operating through SES, treatment, 
and stage pathways 
 
Percent 
Change     
from total to 
direct effect 
Cancer Mortality HR 95% CI P   Mortality HR 95% CI P   Mortality HR 95% CI P   % 
Combined 1.71 (1.59, 1.83) <.001  1.50 (1.39, 1.62) <.001  1.14 (1.10, 1.18) <.001  24% 
ALL 1.47 (1.18, 1.82) .002  1.23 (0.97, 1.57) .11  1.19 (1.08, 1.30) <.001  45% 
AML 1.69 (1.38, 2.09) <.001  1.47 (1.16, 1.86) .002  1.15 (1.03, 1.29) .022  27% 
HL 1.74 (1.11, 2.74) .023  1.55 (0.90, 2.64) .13  1.13 (0.84, 1.52) .44  22% 
NHL 1.60 (1.18, 2.17) .005  1.37 (0.97, 1.94) .10  1.17 (0.98, 1.40) .11  33% 
Astrocytomas 1.91 (1.54, 2.38) <.001  1.54 (1.26, 1.89) <.001  1.24 (1.04, 1.48) .023  33% 
Other CNS 1.53 (1.25, 1.87) <.001  1.40 (1.11, 1.76) .010  1.10 (0.97, 1.23) .14  21% 
Neuroblastoma 1.59 (1.24, 2.04) <.001  1.22 (0.95, 1.58) .14  1.30 (1.09, 1.55) .006  57% 
NRSTS 1.44 (1.10, 1.88) .013   1.37 (1.01, 1.85) .057   1.05 (0.85, 1.30) .64  14% 
Notes: Mortality hazard ratios (HR) compare all-cause mortality in black versus white cases. Inverse odds weighting method used to test for mediation. Models adjusted for age 
category, sex, and year of diagnosis. Surgery and stage do not apply to leukemias. P-values adjusted for multiple comparisons using the Benjamini-Hochberg method. Combined 
= all cancer diagnoses; ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; other CNS = non-
astrocytoma central nervous system tumors; NRSTS = non-rhabdomyosarcoma soft tissue sarcomas. 
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Table 4-8 Associations of SES predicting treatment and stage for combined and individual childhood cancers, ages 0 to 19 
years, SEER 18 registries, 2000-2011 diagnoses (N=27,741) 
  Radiation  Surgery  Distal Stage 
Cancer OR 95% CI P    OR 95% CI P    OR 95% CI P  
Combined 0.98 (0.96, 1.00) .10   1.03 (1.01, 1.05) <.001   0.98 (0.96, 1.00) .022 
ALL 0.97 (0.91, 1.04) .45   n/a n/a n/a   n/a n/a n/a 
AML 0.98 (0.86, 1.11) .73   n/a n/a n/a   n/a n/a n/a 
HL 1.03 (0.97, 1.09) .40   1.06 (0.99, 1.13) .076   1.03 (0.96, 1.10) .43 
NHL 0.98 (0.88, 1.09) .71   0.94 (0.87, 1.02) .15   0.96 (0.89, 1.04) .33 
Astrocytomas 0.95 (0.88, 1.02) .15   1.01 (0.93, 1.10) .86   0.95 (0.76, 1.18) .62 
Other CNS 1.00 (0.93, 1.07) .94   1.02 (0.91, 1.13) .78   1.02 (0.92, 1.12) .75 
Neuroblastoma 1.01 (0.92, 1.11) .89   1.15 (1.05, 1.27) .004   1.02 (0.94, 1.10) .64 
NRSTS 1.02 (0.93, 1.12) .65   1.16 (1.02, 1.31) .020   1.00 (0.88, 1.13) .99 
Notes: Odds ratios (OR) and 95% confidence intervals (CI) estimated from multivariable logistic regression models of SES (modeled ordinally) predicting each prognostic factor 
(tested separately) adjusted for age category, sex, year of diagnosis, and race. Surgery and stage not applicable (n/a) to leukemias. Combined = all cancer diagnoses; ALL = acute 
lymphoblastic leukemia; AML = acute myeloid leukemia; HL = Hodgkin lymphoma; NHL = non-Hodgkin lymphoma; other CNS = non-astrocytoma central nervous system 
tumors; NRSTS = non-rhabdomyosarcoma soft tissue sarcomas. 
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Discussion 
Key Findings  
A fundamental goal of childhood cancer research is to identify non-genetic, 
socially patterned, risk factors of incidence and survival. This dissertation contributed to 
this aim by investigating three key questions in the literature: do pregnancy-related 
exposures contribute to the rise in childhood cancer incidence over time; is there an 
association between SES and childhood cancer incidence; and what is the underlying role 
of social versus biological factors in explaining black-white racial survival disparities? 
Each of these questions was addressed using robust population-based data and advanced 
statistical methods. Findings emerged in each of the three investigations that provide 
insight for future childhood cancer research. 
In manuscript 1, we confirmed increasing temporal trends in incidence rates of 
combined cancers, ALL, AML, CNS tumors, and hepatoblastoma among children, 0 to 4 
years of age, in the United States. We found preliminary evidence of a temporal 
association between increasing county-level average maternal age and county-level 
childhood cancer incidence rates. Specifically, we showed through descriptive analysis 
that the county-level temporal trend towards older average maternal age aligns with rising 
county-level childhood cancer incidence rates. Further, in regression analysis, we found 
that adjustment for only county-level average maternal age substantially attenuated the 
estimated average annual percent change in incidence of combined and individual 
childhood cancers. However, the estimated effect of maternal age on cancer incidence 
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trends was much weaker in models fully adjusted for other county-level pregnancy-
related and sociodemographic characteristics, which suggests that temporal associations 
of maternal age and childhood cancer incidence may be confounded or counteracted by 
other risk factors. We found no evidence that county-level trends in birthweight, birth 
order, or sociodemographic factors are associated with the rise in childhood cancer 
incidence over time. Overall, we did not find conclusive evidence in support of our 
hypothesis that temporal trends in established pregnancy-related risk factors account for 
the rise in childhood cancer incidence over time.   
In manuscript 2, we found an adverse crude association between higher SES and 
incidence of combined childhood cancers, ALL, lymphomas, CNS tumors, 
neuroblastoma, and Wilms’ tumor. However, adjustment for established demographic 
and pregnancy-related risk factors substantially attenuated these adverse associations 
towards the null. In fact, no statistically significant adverse associations between higher 
SES and childhood cancer incidence remained in fully adjusted models. We identified 
non-Hispanic white race/ethnicity, older maternal age, and higher birthweight as the 
primary factors contributing to adverse associations between higher SES and childhood 
cancer incidence. Results were comparable whether SES was measured at the individual-
level or neighborhood-level. These findings suggest that, beyond the social patterning of 
established demographic and pregnancy-related risk factors, SES has a limited impact on 
childhood cancer incidence, at least for the most common cancers. 
In manuscript 3, we replicated prior findings that non-Hispanic white children 
have a significant survival advantage over non-Hispanic black children for combined 
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childhood cancers, leukemias, lymphomas, CNS tumors, neuroblastoma, and non-
rhabdomyosarcoma STS. Through formal mediation analysis, we demonstrated that SES 
explains a portion of the black-white racial disparity in childhood cancer survival, 
particularly for childhood leukemias. Specifically, we estimated that SES accounts for 
20% of the disparity for combined childhood cancers, and nearly half of the disparity for 
ALL. We also found that prognostic factors, including treatment and tumor stage at 
diagnosis, account for some of the survival difference by race, particularly for 
astrocytomas and neuroblastoma. These prognostic factors were not associated with SES 
among astrocytoma cases. Only surgery was associated with SES among neuroblastoma 
cases, though surgery was not associated with race among these cases. Thus, findings 
from this analysis suggest that both social and biological factors may contribute to 
survival differences by race, though to varying degrees across types of childhood cancer.  
Future Directions 
These findings provide direction for future childhood cancer research. Pregnancy-
related risk factors of childhood cancer incidence are well documented in the literature, 
and were further confirmed in our manuscript 2 analysis. However, we did not find 
conclusive evidence linking these exposures to rising childhood cancer incidence rates 
over time. In manuscript 1, comprehensive adjustment for county-level pregnancy-related 
and sociodemographic characteristics had little impact on the estimated average annual 
percent change in combined and individual childhood cancer incidence in the United 
States. Therefore, additional time series research is needed to better understand the cause 
of rising childhood cancer incidence rates over time.  
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Given the limitations of our manuscript 1 study, further research with more robust 
data is needed to confirm temporal associations between pregnancy-related exposures and 
childhood cancer incidence. For example, because our study only consisted of 194 
counties, future time series studies should test temporal associations in larger samples. 
Further, because we used data aggregated at the county-level, future studies should test 
temporal associations using smaller units of observation, such as census tracts. Stronger 
temporal associations may emerge in ecologic studies conducted at finer levels of 
observation in which there is less heterogeneity in exposure and covariate levels within 
groups.61 We found some evidence for this in the manuscript 1 sensitivity analysis testing 
temporal associations within subsets of our sample restricted by county size, which 
revealed that maternal age accounted for a much greater proportion of the annual trend in 
childhood cancer incidence among smaller counties. Birth and cancer registry data linked 
at the individual-level could also be used to assess temporal trends in childhood cancer 
incidence. For example, studies could test whether cancer incidence rates increase over 
time when restricted to the population of children born to older mothers (e.g. > 35 years). 
Future studies should also develop and test alternative hypotheses for the temporal rise in 
childhood cancer incidence rates over time. Because we could not conclusively link 
pregnancy-related exposures to increasing childhood cancer incidence rates over time, it 
is possible that other, potentially unidentified, risk factors account for rising rates.    
In terms of developing new research directions, findings from manuscript 2, 
which tested SES patterns in childhood cancer incidence, are somewhat unsatisfying. 
Results from this study suggest that associations between SES and childhood cancer 
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incidence are mainly attributed to the social patterning of established demographic and 
pregnancy-related risk factors of incidence that are already well-documented in the 
literature. Thus, findings from this study provide limited new insight into potential 
childhood cancer risk factors. However, it is informative that we were able to account for 
adverse associations between higher SES and childhood cancer incidence, and that we 
found little evidence of an inverse association between SES and incidence of the most 
common childhood cancers. The lack of a robust association between SES and childhood 
cancer incidence indirectly suggests that other suspected socially patterned exposures, 
such as environmental pollutants, occupational exposures, and health behaviors, may 
contribute little to etiology. Therefore, future childhood cancer research should prioritize 
testing novel risk factors of incidence, rather than continuing to rehash previously 
hypothesized exogenous exposures that, as of yet, have not been firmly linked to 
childhood cancer risk.    
Though we found limited evidence of an association between SES and childhood 
cancer incidence in manuscript 2, findings from manuscript 3 suggest that higher SES is 
associated with improved childhood cancer survival. However, additional research is 
needed to follow-up on our initial findings. First, because we were confined to using an 
area-based index as our primary measure of SES, future studies should test more direct 
measures of individual-level SES, such as parental education or household income. Such 
research may reveal even stronger associations between SES and childhood cancer 
survival, given that area-level and individual-level SES may have independent effects on 
health. Second, additional research is needed to identify underlying pathways through 
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which SES influences survival, such as differences in treatment protocol and adherence. 
This line of research may directly inform intervention efforts addressing childhood 
cancer survival disparities. Finally, because SES did not fully account for survival 
differences in our study, future studies should explore the potential role of non-social 
factors in explaining childhood cancer survival differences by race. Given the limitations 
of SEER data, we were not equipped to account for factors such as tumor biology and 
treatment efficacy in our analysis. Thus, studies with more extensive data on tumor and 
therapeutic characteristics, as well as socioeconomic indicators, are needed to further 
tease apart the role of social versus biological factors in childhood cancer outcomes.  
Strengths and Limitations 
A primary strength of this dissertation was the use of population-based registry 
data in each of the three investigations. This reduced several potential sources of bias that 
can arise in epidemiologic studies including recall bias, interviewer bias, and selection 
bias. Selection bias is of particular concern when studying socioeconomic exposures in 
participation-based case-control studies. This is because controls in studies requiring 
active participation tend to be higher SES than the source population of interest.116 
Therefore, the use of registry data is a notable strength in manuscript 2 specifically.  
A second key strength of this dissertation was the use of innovative and robust 
datasets to test study hypotheses. We combined multiple existing data sources, some of 
which are not readily available for public use, through record linkage. In manuscript 1, 
we received special access to birth registry data with county-level identifiers from the 
National Center for Health Statistics (NCHS). NCHS provided us with birth data from all 
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fifty states for years 1970 to 2013. This allowed us to explore temporal associations by 
linking birth data to SEER cancer registry data at the county-level. To further enrich this 
dataset, we linked county-level sociodemographic data from the US Census Bureau. In 
manuscript 2, we collaborated with the Minnesota Department of Health to link 
Minnesota birth registry data to the Minnesota Cancer Surveillance System for years 
1989 to 2014. This allowed us to overcome the dearth of individual-level socioeconomic 
data in cancer registries by merging variables from birth records. We also linked census 
tract socioeconomic data from the US Census Bureau, which allowed us to test 
associations of SES at multiple levels of exposure. Access to the Minnesota birth registry 
also provided us with an enumerated source cohort from which we could randomly 
sample controls. In manuscript 3, we were granted access to the census tract SES index, 
available in the restricted SEER database, for years 2000 to 2012. By using this variable, 
we improved upon prior cancer studies that relied on county-level measures, available in 
the public-use SEER dataset, to approximate individual-level SES.49  
A third strength of this dissertation was the use of advanced statistical methods 
that are not commonly employed in the childhood cancer literature. In manuscript 1, we 
used Poisson mixed models to test temporal associations of childhood cancer incidence in 
time series data. In manuscript 2, we used logistic mixed models to test multilevel 
associations of SES and childhood cancer incidence. In manuscript 3, we used the 
semiparametric inverse odds weighting (IOW) method to test for mediation of 
associations between race and childhood cancer survival. Few studies in the childhood 
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cancer literature currently employ multilevel methods to test etiologic associations, and 
no prior study has used the IOW method to test for mediation. 
Although we improved upon past research through the use of population-based 
registry data, there were notable limitations to the data in each of our three investigations. 
In manuscript 1, we were confined to conducting an ecologic analysis at the county-level 
because we lacked individual-level or smaller area (e.g. census tract) identifiers to merge 
birth and caner data. In manuscript 2, we could only test individual-level measures of 
SES available in birth records between 1989 and 2014, which restricted us to parental 
education. We could not assess other dimensions of SES at the individual-level, such as 
household income or parental occupation. In manuscript 3, we could not test SES at the 
individual-level, except in a secondary analysis of health insurance status, which was 
confined to cases diagnosed 2007-2011 (when health insurance data became available in 
SEER). We were also restricted by limited SEER data on tumor and therapeutic 
characteristics, which may be essential for fully understanding survival differences by 
race. Given these noted limitations, a key takeaway from this dissertation is the need for 
more robust data collection in population-based datasets, such as US cancer registries. In 
particular, there is a need for more widespread collection of socioeconomic data in these 
types of data sources. Only so much progress can be made to identify and understand 
social determinants of health with existing population-based registry data, which are 
often used to study rare outcomes, such as childhood cancers.  
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Conclusions  
Though many unknowns remain in the childhood cancer literature, this 
dissertation offers insight into the role of non-genetic, socially patterned, risk factors of 
incidence and survival. We confirmed the role of socially patterned demographic and 
pregnancy-related risk factors in childhood cancer incidence, though we were unable to 
conclusively link these factors to trends in childhood cancer incidence over time. 
Indirectly, our findings suggest that other socially patterned exposures, such as air 
pollutants and occupational toxins, may contribute little to childhood cancer risk, at least 
for the most common cancers. Conversely, we found evidence that SES is associated with 
childhood cancer survival, with the strongest association emerging for childhood 
leukemias. Therefore, though continued study of socioeconomic exposures may generate 
limited new insight into childhood cancer etiology, this line of research may be fruitful 
for understanding and, ultimately, addressing differences in childhood cancer outcomes.  
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